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ABSTRACT
My dissertation work focuses on recent progress made in elucidating the
intermolecular interactions between a novel class of synthetic phenylene ethynylene
(PPE)-based conjugated polyelectrolyte polymers (CPEs) and oligomers (OPEs) and
multiscale cellular targets that give rise to their remarkable broad spectrum biocidal
activity. We studied the interactions and self-assembly behaviors of the CPEs and OPEs
with a set of vital biomolecules, including lipids, proteins and nucleic acids, that reveal
the potential pathways by which the synthetic biocidal agents could exert toxicity. Then,
we explored the antimicrobial effects and mechanisms of the CPEs and OPEs on multiple
clinically relevant pathogens, with an emphasis on the morphological damages induced
by the biocidal compounds towards the pathogens. The discussion about the cytotoxicity
of these materials against mammalian cells and human tissues to can help us to explore
the potential applications of the CPEs and OPEs as antiseptics. We also pose some
unanswered questions about their antimicrobial mechanisms, which provide directions for
the future study.
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Chapter 1. Introduction
1.1 Antimicrobial materials and mechanisms
The outbreak of global infectious diseases presents a major threat to public health. A
recent example is the appearance and the subsequent rapid spread of haemolytic uraemic
syndrome caused by enterohemorrhagic E. coli in Germany that has killed and sickened
over 500 people (May 2011). The development of novel and effective antimicrobial
agents is thus a critical worldwide healthcare need, especially for hospital environments
where antibiotic resistance is prevalent.1 One specific challenge is infections associated
with medical implants and devices. As such, the development of antimicrobials that can
be easily processed to form antiseptic surfaces is also critically needed.2-3
In the past two decades, a number of antimicrobial materials have been discovered and
developed to combat pathogenic agents, including antibiotics, naturally occurring
antimicrobial peptides (AMPs), and synthetic quaternary ammonium compounds.4-5
However, antibiotics need to be used with caution because of the possibility of pathogens
developing resistance.6 AMPs are believed to act by non-specific mechanisms thus
reducing the likelihood of induced resistance.7 However, the development of AMPs as
viable therapeutics has proven difficult due to the high cost of manufacturing, and to
chemical, proteolytic, and physical instabilities of peptide-based materials,8-9 toxicity,
limited efficacy, and poor tissue distribution.10-11 Synthetic mimics that capture the
essential features and functions of AMPs while eliminating their disadvantages are thus
particularly appealing antimicrobial agents. One such class of compounds is phenylene
ethynylene (PPE)-based conjugated polyelectrolyte polymers (CPEs) and oligomers
(OPEs) that exhibit broad-spectrum antimicrobial properties.12 A briefly review about
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some well-known chemical biocidal agents and their biocidal mechanisms against
bacteria13-14 will be discussed and then followed by an introduction to the physical and
biocidal properties of the CPEs and OPEs in the next section. The mechanisms of action
for some typical antiseptics and disinfectants are listed in Table 1.1.
Table 1.1. Summary of mechanisms of selected antiseptics and disinfectants.

Reprinted with permission from ref. 13.
1.1.1 Antimicrobial agents that affect bacterial cell wall
Peptidoglycans are the main component of most bacterial cell walls, which protects the
cell from the outside environment. Living active cells can constantly synthesize
peptidoglycan for growth and propagation. In addition, the surface of Gram-negative
bacteria is a layer of negatively charged lipopolysaccharides (LPS), which is stabilized by
cationic divalent ions. Agents such as penicillin and EDTA can inhibit the synthesis of
peptidoglycan and/or destabilize the cell wall. Penicillin can react with the peptidoglycan
synthesis enzymes and create weak points on the cell wall and make the cell wall
osmotically fragile.14 EDTA can strongly chelate with the cationic divalent ions on the
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outer membrane of the Gram-negative bacteria, then cause the release of LPS and change
the permeability of the outer membrane.15
1.1.2 Antimicrobial agents that affect nucleic acid synthesis
The synthesis of DNA and RNA is a multistep enzyme-catalyzed reaction, which is
subject to attacks at many points.14 Antimicrobial agents, such as chloroquine,
pyrimidines and halogens can cross the cell wall and membrane and interfere with
nucleic acid synthesis. For example, chloroquine can bind and cross-link the DNA double
helix. Hypochlorous acid (HOCl) has also been reported to be cable to completely inhibit
the growth of E. coli cells by terminating DNA synthesis.16
1.1.3 Antimicrobial agents that block protein synthesis and denature protein
As with nucleic acid synthesis, protein synthesis in a living cell is also a long series of
reactions. Aminoglycosides can insert into bacterial ribosome and mislead the mRNA to
synthesize abnormal proteins.16 Proteins are also fairly reactive with other chemical
agents, such as aldehydes and oxidants, largely due to the reactive functional groups on
the side chains of the protein. Glutaraldehyde, an important sterilizing agent, can strongly
react with free amine groups on the protein and cross-link the proteins on the cell surface
and elsewhere in the cell.
1.1.4 Antimicrobial agents that disrupt cell membrane function
The cell membrane carries out many vital functions, including serving as a sealed
barrier. A damaged membrane can easily cause the death of the cell because of the
disruption of metabolism and/or release of the cell contents.14 Antimicrobial drug
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polymyxins have been demonstrated to insert into the cell membrane and cause the
release of proteins and nitrogen bases. Recently, a large class of antimicrobial
macromolecules has been designed and developed.17-18 The amine groups on these
synthetic polymers, especially the quaternary amine, give these materials high
antimicrobial activity. Most of these polymers have been referred to as membrane active
agents, which implies a membrane-disrupting mechanism for their antimicrobial actions.
Since most of the current antimicrobial agents are either not efficient (especially after
the appearance of multi-drug resistant superbugs) or too toxic to treat patients, there is
still a great need for creation of new non-toxic broad-spectrum antimicrobial agents.17
1.2 Conjugated polyphenylene ethynylenes (CPEs) and oligo phenylene ethynylenes
(OPEs)
1.2.1 Synthesis of the CPEs and OPEs
The CPEs and OPEs are a class of π-conjugated polymers and oligomers containing
ionic side functional groups.19-20 Depending on the charge of the functional groups, the
CPEs and OPEs can be classified into these categories: cationic, anionic and
polyampholytes having both anionic and cationic groups. The most common cationic side
groups include quaternary ammonium and pyridinium. While the anionic groups
generally are carboxylate, phosphonate, and sulfonate.
In the past two decades, a significant amount of the conjugated electrolytes with
various structures have been synthesized, mostly through the carbon–carbon bondforming reactions. The most widely used polymerization methods have been summarized
by Liu and are shown in Scheme 1.1, which include FeCl3-catalyzed or electrochemical
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oxidization; the Yamamoto and Suzuki coupling reactions for poly(arylene)s; the Wittig,
Gilch, Wessling, and Heck reactions for poly(arylene vinylene)s; and the Sonogashira
coupling reactions for poly(arylene ethynylene)s.”19 The ring-opening metathesis
polymerization of cyclooctatetraenes has also been widely used to prepare polyvinylene
and its derivatives. Using these well-established methods, the conjugated polyelectrolytes,
as well as the oligoelectrolytes, can be synthesized with various precursors. The CPEs
and OPEs used in our study are entirely made by the palladium-catalyzed coupling
methods (Sonogashira reactions). One example for the synthesis of a typical CPE is
shown in Scheme 1.2.21
Scheme 1.1. Examples of most widely used polymerization methods; Ar, Ar1, and Ar2
represent aromatic structures.

Reprinted with permission from ref 19.
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Scheme 1.2. Synthesis of a typical cationic poly(phenylene ethynylene)
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Scheme 1.3. Structures of the antimicrobial oligomers and polymers discussed in this
dissertation.*

7

*n denotes the number of repeat units.
1.2.2 Physical properties of the CPEs and OPEs
The synthetic CPE and OPE materials (Scheme 1.3) are water-soluble and amphiphilic
due to the combination of cationic side and end functional groups and the hydrophobic
PPE backbone.21-23 Many CPEs and OPEs are strongly fluorescent in the UV/visible
region, and the fluorescence can be efficiently quenched by an oppositely charged
quencher through an electron- or energy-transfer process. The efficient light-harvesting
properties of these materials can result in low-lying singlet and triplet states that are
capable of sensitizing singlet oxygen and generating reactive oxygen species (ROS)
under UV/visible light irradiation, one example for the a representative CPE serving as an
efficient singlet oxygen sensitizer is shown in Figure 1.1.12 In particular, the presence of
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the charged groups in the CPEs and OPEs allows them to interact strongly with
oppositely charged ions in aqueous solutions and with charged planar or colloid
surfaces/scaffolds, such as carboxymethylcellulose (CMC), carboxymethylamylose
(CMA), DNA, and bovine serum albumin (BSA).22, 24 Binding of the CPEs and OPEs
towards these scaffolds results in pronounced changes in photophysical properties of
these materials.
Nucleic acids, including DNA and RNA, are negatively charged at physiological pH.
The cationic CPEs and OPEs are expected to interact with nucleic acids and possibly
induce structural and/or chemical damage. The oligomeric OPE-2 has been demonstrated
to bind, in a sequence-specific fashion, to the minor groove of the double-stranded DNA,
making it a potentially useful compound for DNA sensing and detection.25 Changes in
DNA sequence, as small as a single nucleotide mismatch, can be detected via the changes
in absorption, fluorescence and the induced CD signal of the oligomer that results from
conformational and/or aggregation state change (possible formation of a J-dimer) the
oligomer undergoes upon associating with DNA. The oligomeric OPE-n, S-OPE-n(H),
and S-OPE-n(COOEt) are also found to readily bind to and self-assemble on anionic
cellulose material such as CMC and CMA. Due to their opposite charges, OPE-cellulose
association is likely controlled by electrostatic interactions. Additionally, electrophilic,
nucleophilic and hydrophobic interactions are also expected to contribute to OPEcellulose binding. Changes in the absorption and fluorescence spectra of the OPEs upon
complexing with celluloses reveal that the smallest oligomers with just three phenyl rings
could form a J-dimer on these anionic scaffolds. However, the observed spectral changes
of larger oligomers upon associating with CMC and CMA can also be explained by the
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planarization of the segment chromophores and the extension of the effective conjugation
length within the molecular backbone of these larger oligomers rather than the formation
of aggregates.
Due to the high molecular weight and relatively amphiphilic properties of the CPEs,
they readily self-assemble into nano-scale aggregates in aqueous environments through
intra- and/or inter-chain hydrophobic interactions. In contrast, the smaller OPEs in
aqueous solutions are believed to be monomeric in the micromolar range. A
computational study of a set of oligomers (S-OPE-n(H), n=1, 2 and 3, Scheme 1.3) found
that the backbone of the smallest S-OPE-1(H) is planar and fully conjugated. However,
the larger oligomers (S-OPE-2(H) and S-OPE3(H)) adopt non-planar conformations and
the frontier orbitals of these larger oligomers are confined to near-planar regions, which
are called “segment chromophores” (Figure 1.2).22 These segment chromophores extend
only to about 3 to 4 phenyl rings in length. Although the maximum absorption
wavelengths of the CPEs and OPEs red-shift as the number of repeat unit first increases,
there is little change when comparing the spectrum of S-OPE-3(H) to that of a CPE with
49 repeat units,26 due to the existence of the segment chromophores within the molecular
backbone of these PPE-based conjugated materials.

Figure 1.1. (a) Transient absorption difference spectra of PPE-DABCO in methanol, (b)
schematic representation for the formation of singlet oxygen sensitized by the CPE, and
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(c) singlet oxygen emission at λ≈1260 nm sensitized by PPE-DABCO in CD3OD.
Note to figure 1.1: This work has been done in Dr. Kirk S. Schanze’s lab at University of Florida. Transient
absorption spectroscopy has been used extensively to study the triplet states of cationic CPEs and OPEs.
Direct excitation of these PPE-based conjugated materials first produces a singlet excited state that
undergoes intersystem crossing with moderate efficiency (ϕisc = 0.05-0.20) to produce a triplet state (triplet
exciton). The triplet state is readily detected by transient absorption spectroscopy, in which a long-lived (τ
= 5-20 µ s) absorption is observed throughout the visible and into the near infrared region (Figure 1.1a).
The triplet of the PPE polymers is sufficiently energetic (ET ≈ 2.0- 2.2 eV) such that it is able to undergo
energy transfer to ground state triplet dioxygen leading to efficient production of 1O2 (Figure 1.1b).
Evidence that 1O2 is produced is provided by near-infrared photoluminescence spectroscopy carried out
with the cationic CPEs or OPEs in air-saturated CD3OD solution. Here the emission of the 1O2 that is
sensitized by the CPE is readily detected by its characteristic emission at 1260 nm (Figure 1.1c). Quantum
yield experiments indicate that typical cationic CPEs produce 1O2 with yields in the range from 0.01-0.1 in
CD3 OD solution. Modified with permission from ref 12.

Figure 1.2. Computationally optimized structures for the S-OPE-n(H) series. Reprinted
with permission from ref 22. Copyright 2011 ACS Publications.
1.2.3 Biocidal actives of the CPEs and OPEs
These cationic CPEs and OPEs exhibit significant light-enhanced biocidal activity and
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efficient killing efficacy in the dark against a broad spectrum of clinically relevant
pathogens, including bacteria, viruses, fungi and spores.27 Furthermore, most of these
materials are convenient to synthesize and amenable to be processed onto different
substrates, including layer-by-layer coatings, covalent attachment or non-covalent
incorporation into fibers, and capsules, which could greatly expand their applications as
antiseptic materials and surfaces for controlling the spread of pathogens.28-29
The biocidal activity of a PPE-based conjugated polyelectrolyte was first reported by
Lu and co-workers in 2005.30 PPE-OR8 (Scheme 1.3) functionalized with quaternary
ammonium groups has been demonstrated to efficiently bind to the cell envelopes of
vegetative Gram-negative bacteria (Escherichia coli) and Gram-positive bacterial spores
(Bacillus anthracis, Sterne, B. anthracis). Upon irradiation with white light, the
viabilities of the attached bacteria and spores were significantly reduced.13 Subsequently,
the dark and light-enhanced biocidal activities of a series of CPEs have been investigated
and reported.31-32 It is important to note that light-irradiation alone has very limited
toxicity against the model pathogens under our experimental conditions. Since the
polymer chain length of the CPEs can not be precisely controlled and these
macromolecules often have a broad range of molecular weights, oligomeric OPEs with
controlled structures have been synthesized to study the structure-function relationship in
their photophysical and biocidal properties.
The antimicrobial activities of the CPE and OPE materials arise from their interactions
with the microbial targets, specifically the envelope or capsid of the targets, which are
mainly biological assemblies of individual components, such as polysaccharides, proteins
and lipids. Disruption of the structures, and thereby functions, of the biological
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assemblies is one of the main causes of the inactivation of the microbial targets. In
addition, some biomolecules are particularly susceptible to oxidative damages that lead to
the loss-of-function. My dissertation work mainly focuses on the antimicrobial activities
and mechanisms of cationic CPEs and OPEs with an emphasis on their interactions with
the biological molecules and assemblies.
The bactericidal activities of the CPEs and OPEs have been investigated by my
colleagues and collaborators.33 For example, in the dark, most of the tested CPEs and
OPEs at 10 µg/mL can significantly reduce the viability of the bacteria, in the presence of
UV-irradiation, 0.5-1 µg/mL of the tested materials can almost completely kill the
bacteria. The antimicrobial activities and mechanisms against bacteria as well as other
model pathogens for the PPE-based materials will be discussed in the following chapters.
Considering the application of these materials, it is important to study their
cytotoxicity towards humans and activity against biofilms, which are the most common
living form of bacteria in the hospital environment. Our collaborators have tested the
cytotoxicity of two OPEs (S-OPE-2(H) and S-OPE-3(H)) with human endothelial and
epithelial cell monolayers and human skin tissues.33 These studies show that, in the dark,
S-OPE-2(H) is cytotoxic at 10-50 µg/ml and S-OPE-3(H) is cytotoxic at 50-100 µg/ml
against the cell monolayers. In the presence of UV-light, both of the oligomers are toxic
at 5-10 µg/ml. The skin irritation tests results further revealed that neither S-OPE-2(H) or
S-OPE-3(H) is irritating against human skin under the specific experimental conditions
employed in these standardized tests. These studies imply that the CPE and OPE
materials show limited toxicity against mammalian cells and tissues at concentrations
where they can efficiently kill microbial pathogens. (Note: In the cell monolayer test, the
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cytotoxicity for a given test condition is defined as the concentration at which the cell
relative viability is less than 70%. Skin irritation is defined as reversible damage to the
skin after chemical exposure. If the relative viability of the cell in the shin tissue for a
given test condition is greater than 50%, the chemical is considered a non-irritant.)
In most natural and hospital environments, microorganisms exist mainly in the form of
biofilms rather than planktonic cells in solution.34 In biofilms, the microbes are held
together by a self-secreted matrix containing polysaccharides, proteins and DNA, which
provides structural stability and protection for the microbes in the biofilm. In addition,
the metabolic activity in biofilm is not uniform, in that the microbes on the biofilm
surface have a high level of metabolic activity and cells in the center have a slow or no
growth, and the slow growth rate is one reason for the high resistance of the biofilm
microbes against antibiotics.
Recently, the efficacies of a set of oligomeric OPEs in exerting toxicity towards in
vitro E. coli biofilms have been evaluated by my colleagues.35 In the dark, all of the
tested compounds exhibited better or similar killing abilities against the biofilm
compared to the standard antibiotic kanamycin. The minimum biofilm eradication
concentration (MBEC) of some of the tested “End-Only” oligomers (EO-OPE1(DABCO), EO-OPE-1(DABCO Th) and EO-OPE-1(C2)) is in the range of 150-200
µg/ml for 24 h of dark treatment, while the MBEC value for kanamycin is over 1000
µg/ml under the same conditions (Table 1.2). With 1 h of UV-irradiation, the EO-OPEs
exhibited significantly enhanced killing efficiency against the biofilm, with the MBEC
values decreasing 3- to 4-fold compared to the values of 24 h dark treatment.
It is important to note that the high quantum yield for singlet oxygen generation of EO-
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OPE-1 (C2 Th) does not translate to a high killing efficiency against the biofilm, which
could be explained by its nonlinear conformation, which may make it difficult for the
oligomer to penetrate through the biofilm, and the single positive charge of its quaternary
ammonium side groups toward the biofilm as compared to other oligomers bearing the
DABCO side groups with two positive charges. (Note: The MBEC is the lowest
concentration at which bacteria from a biofilm cannot regrow.)
Table 1.2. MBEC values (µg/mL) of the tested oligomers against E. coli biofilm.*
EO-OPE-1
(DABCO)

EO-OPE-1
(Th,
DABCO)

EO-OPE-1
(C2)

EO-OPE-1
(Th, C2)

MBEC
200
150
200
>1000
(dark)
MBEC
60
60
70
200
(light)
*Modified with permission from ref 35. Copyright 2012 ACS Publications.

Kanamycin
>1000
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Chapter 2 Materials and Methods
2.1 Materials
The antimicrobial molecules (Scheme 1.3) used in this dissertation were synthesized as
reported.1-4 The concentrations of CPEs used in this study are based on repeat units and
the concentrations of OPEs used in this study are molar concentrations. 1,2-dioleoyl-snglycero-3-phospho-(1'-rac-glycerol) (sodium salt) (DOPG) (Scheme 2.1), 1,2-dioleoylsn-glycero-3-phosphocholine (DOPC), 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine
(DOPE), 1,2-dipalmitoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt) (DPPG),
1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine (DPPE), E. coli total lipid,
cholesterol and lipid vesicle extrusion supplies were purchased from Avanti Polar Lipids
(Alabaster, AL) and used as received. 5(6)-carboxyfluorescein (hereafter referred to as
fluorescein) was purchased from Sigma-Aldrich (St. Louis, MO). Superfine Sephadex G25 was obtained from GE Healthcare Bio-Science (Piscataway, NJ). Luria broth (LB) and
agar were purchased from BD Biosciences (Franklin Lakes, NJ). Bacteriophages MS2
and T4 were obtained from the American Type Culture Collection (ATCC, Manassas,
VA) along with their host bacteria, E. coli ATCC 15597 and E. coli ATCC 11303. E. coli
strain ATCC 11303 and ATCC 29425, Staphylococcus epidermidis (S. epi) ATCC 14990,
Saccharomyces cerevisiae (S. cerevisiae) strains ATCC 9763 and 204722 were also
obtained from American Type Culture Collection (ATCC, Manassas, VA). The P.
aeruginosa strain PAO1 was a generous gift from Dr. Tim Tolker-Nielsen. All other
chemicals were purchased from Sigma-Aldrich or Alfa Aesar. Ultrapure water was used
throughout the study (Milli-Q, 18.2 MΩ cm-1 resistivity).
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2.2 Multi-scale membrane tests
2.2.1 Preparation of fluorescein-loaded vesicles and vesicle leakage assays
Fluorescein-loaded large unilamellar vesicles (LUV) were prepared by extrusion.5
Briefly, a phospholipid stock solution was dried under a flow of nitrogen and then placed
under vacuum overnight. The dried lipid film was then hydrated to 2-4 mM with 100 mM
fluorescein in water (adjusted to pH 7 with NaOH) with strong shaking for 1 hr at a
temperature above the phase transition temperature of the lipid. The resulting suspension
was subjected to 4 freeze-thaw cycles. Finally, LUVs were formed by extruding the lipid
solution 19 times through a 100 nm pore size polycarbonate membrane using a miniextruder (Avanti Polar Lipids). Free fluorescein was removed from the dye-loaded
vesicles by column filtration (Sephadex G-25 superfine). The mobile phase used was 200
mM NaCl containing 10 mM HEPES at pH 7 (Buffer A). After separation, the
phospholipid concentration of the dye-loaded vesicles was determined by the modified
microprocedure of Barlett.6 The hydrodynamic radii (Rh) of vesicles were determined by
dynamic light scattering (DLS, DAWN HELEOS II, Wyatt Technology Corporation).5
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Scheme 2.1 Structures and phase transition temperatures (Tm) of lipids.7
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Vesicle membrane stability in the presence of CPE/OPE was evaluated by a dyerelease assay.5 CPE or OPE was added to the dye-loaded vesicles at a (CPE/OPE):lipid
molar ratio of 1:50 with a final lipid concentration between 0.2-0.3 mM. As the vesicle
membrane is perturbed by the CPE or OPE, dye is released and the fluorescence intensity
of the released dye was recorded at 520 nm (excitation at 485 nm) (SpectroMax M-5
microplate reader, Molecular Devices).5 The CPE/OPE are not excited at this wavelength.
Fluorescein leakage was calculated using equation (1):

Fluorescei n Leakage =

F − F0
Fmax − F0

(1)

where F0 is the fluorescence intensity of the vesicles before the addition of CPE/OPE, F
is the fluorescence intensity of the sample after the addition of CPE/OPE, and Fmax is the
maximum fluorescence intensity of the sample, achieved by the addition of 1 µL 0.5 M
Triton-X100 solution to 100 µL of vesicles that caused complete lysis of the vesicles.
Fluorescein leakage is taken as a measure of the extent of vesicle membrane disruption
and all experiments were carried out at room temperature.
2.2.2 Photophysical measurements of the CPE/OPE-lipid complexes
The large unilamellar vesicles (LUVs) were made in pure water by an extrusion
procedure as described previously.5 The vesicle and CPE/OPE mixtures were prepared in
pure water and kept at a lipid to CPE/OPE molar ratio of 50:1. The final lipid
concentration was 0.2 mM. To assess changes in the compounds’ conjugation lengths,
absorbance spectra were measured using a microplate reader (SpectroMax M-5
microplate reader, Molecular Devices, Sunnyvale, CA). To assess changes in the
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hydrophobicity of the compounds’ microenvironments, emission spectra were recorded
by a spectrofluorometer (QuantaMaster™ 50 spectrofluorometer, Photon Technology
International, Birmingham, NJ).
2.2.3 Lipid monolayer insertion assays
Insertion of a CPE or an OPE into lipid monolayers held at a constant surface pressure
were measured using a Teflon Langmuir trough equipped with a Wilhelmy plate and two
identical mobile Delrin barriers (MicroMini Trough System, KSV Instruments Ltd.,
Finland).8 The water subphase volume was 50 mL and the maximal working surface area
was 100 cm2. Phospholipids dissolved in a 7:3 chloroform:methanol mixture were first
spread at the air-water interface. The deposited lipids were left undisturbed for 15
minutes to allow the complete evaporation of the organic solvent. The lipids were then
compressed to a target surface pressure (π) of 30 mN/m, a bilayer equivalent pressure,9
and the surface pressure was kept constant via a feedback loop. An aliquot of CPE or
OPE was then injected into the water subphase using a micro-syringe without disturbing
the monolayer. The final concentration of CPE or OPE in the subphase was 0.1 µM. All
experiments were carried out at room temperature. Favorable interactions between the
CPE or OPE that led to the insertion of the compound into the lipid monolayer caused an
expansion of the lipid monolayer surface area at constant pressure. Percentage of surface
area increase was calculated using the following equation:
Percentage of Area Increase =

A− A
×100%(2)
A

where A0 is the trough area before the injection of CPE/OPE, A is the trough area at time t
after the addition of the CPE or OPE.
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2.2.4 Formation and observation of giant vesicles
Giant vesicles were prepared and observed by a method modified from the literature.1011

Lipid mixtures (E. coli Total Lipids extract, 1,2-dimyristoyl-sn-glycero-3-

phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) (ammonium salt) (DMPE-Rh)
and 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-(biotinyl(polyethylene glycol)2000) (ammonium salt) (Biotin-PEG-DSPE) at molar ratio 97:0.5:2.5 respectively) or
DOPE and DOPG at molar ration 80:20 were dissolved in chloroform, dried, and
rehydrated with 10 mM 2-[4-(2-hydroxyethyl)-1-piperazinyl]ethanesulfonic acid (HEPES,
pH 7.4) to a final concentration of 0.33 mg/ml at 37°C for 2 hours. The observation
microchambers (internal volume ~100 µL) were made by microscope slides and cover
slips, and sealed with double-side tape. The microchamber was incubated with
neutravidin solution (0.1 mg/ml in 10 mM HEPES) for 15 min. After rinsing with the
HEPES buffer, the microchamber was incubated with giant vesicle solution for 5 min and
then rinsed again to remove unattached vesicles. A 2 µL aliquot of CPEs or OPEs (50
µg/mL for the OPEs and 10 µg/mL for the CPEs in 10 mM HEPES) were added to the
chamber. The immobilized vesicle was then imaged by a fluorescence microscope (Zeiss
Imager A2, Excitation filter BP 545/25 nm, Emission filter BP 605/70 nm, Thornwood,
NY).
2.2.5 Small angle X-Ray scattering (SAXS)
SAXS experiments were carried out at the Stanford Synchrotron Radiation Laboratory
(Palo Alto, CA) (BL4–2) as described in literature.12 Briefly, E. coli total lipid extract or
mixed 8:2 (molar ratio) DOPE:DOPG lipids were dissolved in chloroform, dried, and
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rehydrated with Millipore water to a final concentration of 25 mg/ml at room temperature.
The vesicle solutions were sonicated for an hour in ice-water bath and extruded through a
100 nm polycarbonate membrane (Avanti) to make small unilamellar vesicles (SUV).
CPEs and OPEs were prepared in water (EO-OPEs was prepared in 10% DMSO in water)
and mixed with the SUVs at various CPE/OPE-to-lipid molar ratios. SAXS data were
collected using 11-keV x-rays.
2.2.6 NMR spectroscopy
31

P solid-state NMR spectra were recorded on a Bruker Avance III Widebore 300 NMR

spectrometer as described in the literature.13 The reported Hahn echo pulse sequence was
used in the current study. The NMR samples were prepared by hydrating a 25 mg dry
phospholipid film with 100 µL water or EO-OPE-1(C3) solution at appropriate
concentrations by vigorous vortexing. In order to thoroughly hydrate the lipid sample and
mix the test compounds with lipid membrane, the samples were subjected to 10 freezethaw-vortex cycles. 7 mm CPMASS probe was used in the NMR spectroscopy.
2.2.7 Cryo-TEM
Cryo-TEM imaging was performed by a modified method from the literature14 at the
Scripps Research Institute. Large unilamellar vesicles (LUV) composed of DOPE:DOPG
(8:2, molar ratio) were made by an sonication-extrusion method to a final concentration
of 10 mg/ml in water at room temperature and mixed with the CPEs or OPEs at various
molar ratios. A 3 µL aliquot of each sample was applied to the grid (Protochips, Raleigh,
NC, CF-2/0.5-4C) and then vitrified in liquid ethane using a Vitrobot (FEI Company,
Hillsboro, Oregon). Cryo-TEM imaging was carried out on an FEI TF20 microscope
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operating at a low lose, 200 kV condition using a Gatan cryo-transfer holder and the
Leginon data collection software.15
2.3 Pathogen culture and biocidal tests
2.3.1 Bacterial growth conditions
All bacterial cells were grown in Luria broth (LB) and E. coli BL21(DE3)pLysS was
grown in Luria broth with carbenicillin and chloramphenicol at concentrations of 50 and
34 µg/ml, respectively. A fresh bacterial culture was inoculated from an overnight culture
followed by approximately three hours of incubation at 37℃ to the exponential growth
phase (O.D.600~0.5-0.8). At this growth phase, the bacterial cells were collected by
centrifugation and washed twice with 10 mM PBS (138 mM NaCl and 2.7 mM KCl at
pH 7.4). The cell pellet was resuspended with PBS buffer to O.D.600~0.5.
The P. aeruginosa cells were prepared in a chemostat.16 Prior to inoculation into a
chemostat, a single colony from a nutrient agar slant was inoculated into fresh of nutrient
broth (NB) and grown overnight. A chemostat culture was established by inoculating the
overnight culture into citrate minimal medium. The chemostat was maintained at a flow
rate of 1.0 mL min-1 with constant stirring. The concentration of the chemostat culture
was maintained at 107 /mL cells.
2.3.2 Yeast strains and culture conditions
S. cerevisiae (ATCC 9763) vegetative cells were grown in YPD medium (1% Yeast
extract, 2% Peptone and 2% Glucose). A fresh yeast culture was inoculated from an
overnight culture and incubated for varying periods at 30°C to obtain different growth
phases. Yeast cells were collected by centrifugation and washed twice with PBS buffer
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(10 mM sodium phosphate, 138 mM NaCl, and 2.7 mM KCl at pH 7.4). The cell pellet
was resuspended with PBS buffer to O.D.600 ~ 1.0. A highly sporulated yeast strain
(ATCC 204722) was used to prepare ascospores/asci. The yeast cells were first grown in
the YPAD medium (1% Yeast extract, 2% Peptone, 0.04% Adenine sulfate and 2%
Glucose) overnight at room temperature. The recovered cells at exponential phase were
pelleted, washed with PBS and then prepared for sporulation on an acetate agar (0.1%
glucose, 0.18% KCl, 0.25% yeast extract, 0.82% sodium acetate ⋅ 3H2O and 1.5% agar)
for one week. The harvested asci were washed, briefly sonicated and resuspended in PBS
to O.D.600 ~ 1.2. The germinated asci or spores were prepared via incubating with the
germination solution (2% glucose and 0.37% NH4Cl) for 20 hours at room temperature.
2.3.3 Antifungal activity
A sample consisting of 10 µg/ml of the CPEs, OPEs, or Amphotericin B (AmB) were
used for the antifungal test against S. cerevisiae vegetative cells (ATCC 9763). The yeast
cell solutions were incubated with the biocidal agents at 30°C in the dark with
continuous shaking for 60 min. The UV-light irradiation experiments were carried out in
a photoreactor (4 UV-lamps, LZC-ORG, Luzchem Research Inc., Ottawa, Canada) at
room temperature for 30 min (Figure 2.1A). Two irradiation sources were employed
based on the different light-absorbing properties of the CPEs and OPEs. LZC-420
(centered at ~420 nm) and UVA (centered at ~350 nm) were used to irradiate CPEs and
OPEs, respectively. The sporicidal activity of the CPEs and OPEs (30 µg/ml) were
evaluated against the asci (ATCC 204722) with or without germination in the dark or
under UV-irradiation (10 lamps in the photoreactor) for 60 min (Figure 2.1B). The ability
of a CPE or an OPE to inactivate vegetative cells and spores was determined by the plate
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counting method and was calculated as log (No/N), where N is the number of colony
forming units (CFU) of the yeast solution after exposure to a CPE or an OPE and No is
the CFU of a control (without biocidal material or UV-irradiation). The Log CFU
reductions caused by the biocidal treatments relative to the control are reported. The
reported values and errors were averages and standard deviations of duplicate
measurements, respectively.

Figure 2.1. Typical photoreactor setups with 4 lamps (A) and 10 lamps (B).
2.3.4 Bacteriophage preparation and titer
E. coli host cells were grown in LB. The fresh E. coli culture was inoculated from an
overnight culture followed by approximately three hours of incubation at 37℃ to the
exponential growth phase (O.D.600~0.5). E. coli cells were then collected by
centrifugation and washed twice with E. coli minimal medium (glucose 28 mM,
Na2HPO4 42 mM, KH2PO4 22 mM, NH4Cl 18.7 mM, NaCl 8.5 mM, MgSO4 1 mM, and
CaCl2 0.09 mM at pH 7.2) . The cell pellet was then resuspended in the minimal medium.
An aliquot of phage stock solution was added to the corresponding bacterial host
suspension and the phage-bacteria mixture was incubated for 15 min at 37 °C. The
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mixture was then transferred into fresh E. coli minimal medium and incubated overnight
for viral replication and cell lysis. The phage solution was then centrifuged at 3500 rpm
for 30 min, and the supernatant was filtered using 0.22-µm filters to remove unlysed
bacteria and bacterial debris. The phage titer was determined by plaque forming units
(PFU). Briefly, E. coli cells in the exponential growth phase (ATCC 15597 and 11303 for
MS2 and T4 bacteriophage, respectively) were incubated with the various dilutions of the
phage solution for 15 min at 37 °C and then transferred into molten soft LB agar with
gentle mixing. The soft agar mixture was then poured onto pre-solidified LB plates. After
incubation for 6-8 hrs, the numbers of PFU were counted and phage solutions were
diluted to 106 ~107 PFU/ml with the minimal medium for further use.
2.3.5 Phage inactivation
CPE and OPE solutions (10 µg/ml) were incubated with virus solutions in the dark or
under UV-light for 1 hour. The UV-light irradiation experiments were carried out in a
photoreactor (10-lamps, LZC-ORG, Luzchem Research Inc., Ottawa, Canada). Two
illumination sources were employed due to the different light-absorbing properties of the
CPEs and OPEs. The viral inactivation ability of a CPE or an OPE was determined by
phage titer as described in the previous section and calculated as log (No/N), where N is
the PFU of the phage solution after exposure to a CPE or an OPE and No is the PFU of a
control (without CPEs, OPEs, or UV-irradiation). Log (No/N) reduced by the different
treatments compared to control are reported. The reported values were averages of
duplicate measurements.
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2.4 Biocidal mechanism investigation
2.4.1 Destruction of bacterial cell walls and membranes
An aliquot of pathogen suspension (~106-8 colony forming units (CFU)/mL) was mixed
with 10 µg/ml CPEs, OPEs or melittin followed by incubation at 37℃ for various periods
in the dark or under UV-irradiation. The mixture of the pathogen cells and antimicrobial
material was centrifuged at 3,000-10,000 rpm for 10 minutes to collect the samples.
The supernatant of the E. coli samples were decanted and its absorbance at 260 nm was
measured (300 µL for the 96-well plate on the SpectroMax M2e microplate reader,
Molecular Devices, Sunnyvale, CA). The UV-light irradiation experiments were carried
out in a photoreactor (10 lamps, LZC-ORG, Luzchem Research Inc., Ottawa, Canada) at
room temperature as described before.
The cell pellets were resuspended with 2% glutaraldehyde and incubated at 4 °C for
three hours to preserve the interface between pathogen cells and antimicrobial
compounds, followed by washing with PBS buffer. Then, the fixed cells were dehydrated
by sequential treatment with increasing concentrations of ethanol for 15 minutes and
dehydrated with absolute ethanol twice. The dehydrated samples were dried at room
temperature and transferred onto a piece of clean silicon wafer. The dried samples were
sputtercoated with 10 nm thick gold/palladium. Morphologies of the bacterial cells were
observed by SEM (Quanta 3D, Dual beam FEGSEM/FIB, FEI, Hillsboro, OR). For TEM
imaging, cell pellets were fixed with 2% glutaraldehyde for one day and then 1% osmium
tetroxide for one hour at room temperature. The samples were dehydrated by sequential
treatment with increasing concentrations of ethanol. Then, the cells were embedded in
resin (Spurr's resin kit, Electron Microscopy Sciences, Hatfield, PA), sectioned and
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imaged by TEM (Hitachi H7500, Tokyo, Japan).
E. coli (ATCC 29425) and PAO1 cells (~108/ml) were incubated with OPE-1 (42.5
µg/ml) for 60 min in 0.85% NaCl sterile solution and kept in the dark. Then, the samples
were stained with SYTO 60/SYTOX Green21 (Molecular Probes, Carlsbad, CA) and
examined by Laser Scanning Confocal Microscope (Zeiss LSM 510 Meta, Thornwood,
NY) as described previously.
2.4.2 Bacterial cytoplasmic membrane permeability assay
Cytoplasmic membrane permeabilization caused by the addition of CPE compounds
and melittin was determined by a modified protocol from literature.17 The E. coli cells are
first diluted to 107 CFU/ml with the HEPES buffer (5 mM HEPES and 5 mM glucose at
pH 7.2) followed by the addition of the membrane potential-sensitive cyanine dye diSC35 to a final concentration of 0.4 µM. The mixture of E. coli cells and diSC3-5 was
incubated in the dark for one hour. Then 100 mM KCl and various amounts of OPEs or
melittin were added to the E. coli suspensions and incubated for another 30 minutes in the
dark. Emission intensity of diSC3-5 was recorded by a spectrofluorometer at 674 nm
(QuantaMaster 50 spectrofluorometer, Photon Technology International, Birmingham, NJ)
with an excitation wavelength of 651 nm. A negative control sample was also prepared
by incubating E. coli cells with the dye. The fluorescent intensity of this control was used
as background. The membrane permeability assays were run in duplicates and the
measurements were reproducible. Since the CPEs can strongly influence the fluorescence
of diSC3-5, the effect of CPEs on membrane permeability was not determined.
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2.4.3 Circular dichroism tests on model proteins
An aliquot of a CPE or OPE was added to 3 mL of 0.1 mg/mL model protein solution
in 10 mM phosphate buffer (2 mM NaH2PO4 and 8 mM Na2HPO4 at pH 7.4) and
incubated at 37℃ for one hour in the dark. The final concentration of CPE or OPE was
10 µg/mL. Circular dichroism spectra from 200 to 500 nm were recorded on an Aviv CD
spectrometer (Model 420, Aviv Biomedical Inc.) in quartz cuvettes at room temperature.
2.4.4 Minimum inhibitory concentration (MIC) determination against bacteria
MIC values were determined by a modified method from literature.18-19 The E. coli and
PAO1 cells were diluted with the minimal medium (28 mM glucose, 42 mM Na2HPO4,
22 mM KH2PO4, 18.7 mM NH4Cl, 8.5 mM NaCl, 1 mM MgSO4, and 0.09 mM CaCl2 at
pH 7.2. 50 µg/ml carbenicillin and 34 µg/ml chloramphenicol were added to the medium
for E. coli BL21(DE3)pLysS) to ~105 CFU/ml. The diluted cell solutions were then
incubated with twofold serial dilutions of the antimicrobial compounds in a 96-well plate
at 37℃ overnight. O.D.600 was obtained on a microplate reader (SpectroMax M2e,
Molecular Devices, Sunnyvale, CA) to monitor cell growth. The MIC values (MIC90)
reported herein are the minimum concentrations needed to inhibit 90% of the cell growth.
Positive controls without antimicrobial compounds and negative controls without bacteria
were also measured. The reported values are the averages of duplicate measurements.
2.4.5 Hemolysis assay
The hemolytic activities of CPEs, OPEs and melittin were determined by the release of
hemoglobin from human red blood cells (RBCs) when incubated with the antimicrobial
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compounds.19-20 Fresh human RBCs were obtained by centrifuging human whole blood at
2,000g for 5 min and washed with Tris buffer (10 mM Tris and 150 mM NaCl at pH 7.2).
A RBC stock solution was made by a 200-fold dilution of the RBC suspension (0.5% red
blood cell) with the Tris buffer. The RBC stock solutions along with various amounts of
the antimicrobial compounds were incubated at 37℃ for 1 hour in microcentrifugation
tubes. Then, the mixtures were centrifuged at 3500g for 10 minutes. 100 µL aliquots of
the supernatant were transferred to a 96-well plate and mixed with 100 µL of Tris buffer.
The hemolytic concentrations (HC50, concentrations of antimicrobial compounds that
caused 50% cell hemolysis) were determined by measuring the absorbance of
hemoglobins at 540 nm using a microplate reader (SpectroMax M5, Molecular Devices,
Sunnyvale, CA). A positive control of cells incubated with 1% Triton-X100 was also
prepared. A negative control of the RBC solution without antimicrobial compounds was
also prepared. The reported values were the averages of duplicate measurements.
2.4.6 Protein SDS-PAGE and DNA electrophoresis
SDS-PAGE and DNA electrophoretic methods were used to characterize protein and
DNA damage in E. coli cells. Fresh E. coli cells in exponential growth phase (4×108
CFU/mL) were incubated with 25 µg/ml EO-OPE-1(C3) in PBS in the dark or under UV
irradiation for 1 hour. A 12 µL aliquot of each E. coli sample was mixed with 6 µL of 3X
standard SDS-PAGE sample loading buffer and heated in boiling water for 10 min
followed by centrifugation. The supernate of denatured cell samples was loaded directly
onto the 12% precast polyacrylamide-gel (BIO-RAD, 456-1043S). Electrophoresis was
performed at 200 V for approximately 30 min, after which the gel was stained with
Coomassie brilliant blue R. For DNA electrophoresis, fresh bacterial cells (E. coli
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BL21(DE3), 1×108 CFU/mL) were incubated with 1 µg/mL EO-OPE-1(C3) in PBS in the
dark or under UV irradiation for 1 hour. The plasmid DNA was extracted from each
bacterial sample using a Miniprep Kit (QIAGEN Inc., Valencia, CA) according to the
manufacturer’s manual. A 10 µL aliquot of each plasmid sample was mixed with 2 µL of
6X loading buffer and loaded onto a 1% agarose-gel. Electrophoresis was carried out at
100 V for approximately 40 min.
2.4.7 Yeast cell SEM imaging
Samples for ultrastructural examination were prepared as described above. For SEM
imaging, cell pellets were resuspended in 2.5% glutaraldehyde and incubated at room
temperature overnight to preserve the interface between the cells and antimicrobial agents,
followed by washing with PBS buffer. Fixed cells were dehydrated by sequential
treatment with increasing concentrations of ethanol for 30 minutes. The dehydrated
samples were dried at room temperature and sputtercoated with ~12 nm thick
gold/palladium. Samples were observed by SEM (Quanta 3D, Dual beam FEGSEM/FIB,
FEI, Hillsboro, OR).
2.4.8 Phage TEM imaging
High concentrations of the viruses (~1011 PFU/ml for T4 and ~1012 PFU/ml for MS2)
and CPE or OPE (50 µg/ml) were used for TEM imaging (Hitachi H7500, Tokyo, Japan).
The same phage inactivation protocol was used as described in the previous section.
Samples (5 µL) were applied to freshly cleaned carbon-coated copper grids, washed with
pure water, and negatively stained with 2% uranyl acetate for 2 min. The grids were then
dried in air and imaged at 70-100K fold magnification with 200µm condenser aperture
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and 20µm objective aperture.
2.4.9 Phage SDS-PAGE
SDS-PAGE method was used to characterize MS2 phage capsid protein cleavage.21
One liter MS2 phage was prepared as described above and purified according to a
modified protocol.22-23 Briefly, the purification of MS2 phage particle was performed by
separating unlysed E. coli cells and cell debris by centrifugation followed by
poly(ethylene glycol)-8000 (PEG-8000)/NaCl selective precipitation. After an overnight
incubation at 4°C, the fine precipitates were collected by centrifugation at 18,000 rcf for
1 hr at 4 °C. The pellet was collected and resuspended in TNM buffer (10 mM Tris, 100
mM NaCl and 0.1 mM MgCl2 at pH 7.4). The phage suspension was passed through a
0.22-µm filter, and the filtrate was concentrated by an Amicon centrifuge filter with a
molecular weight cut-off of 30000 (Millipore, Billerica, MA). Further purification of the
phage particles was accomplished by Sepharose CL-4B (Sigma) column to remove
residual PEG-8000, DNA, and RNA from the host cells. Then, the purified phage
solution was incubated with EO-OPE-1(Th) under UV light or in the dark for 1 hour. 20
µl of the inactivated phage sample was mixed with 10 µl of 3X standard SDS-PAGE
sample loading buffer and heated in boiling water for 2 min. The denatured virus samples
were loaded directly onto the gels. Electrophoresis was performed at 30 mA for
approximately 1 hour, after which the gel was stained with either silver (Silver Stain Plus
Kit, Bio-Rad) or Coomassie brilliant blue R.
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Chapter 3. Interaction of the CPEs and OPEs with Model Lipid Membranes
3.1 Introduction
3.1.1 Introduction to the membrane perturbation test
Recent investigations have shown that the naturally occurring antimicrobial peptides
and their synthetic mimics mainly target the lipid bilayer of the bacterial membrane and
that the membrane perturbation ability of these molecules is highly dependent on the lipid
composition of the membrane.1-5 Both the light-activated and dark biocidal activities of
CPEs and OPEs are also linked to their interactions with bacterial cell membranes.6 Thus,
it is important to understand the structure-function relationship of our CPEs and OPEs
with lipid membranes. Moreover, because of the significant differences in the lipid
composition between prokaryotic and eukaryotic cell membranes,7 understanding the
interaction of CPEs and OPEs with different lipid membranes is of primary importance.
Although the CPEs and OPEs are structurally diverse, they are generally amphiphilic
due to the hydrophilic, charged side chains positioned along the rod-like hydrophobic
PPE backbone. In order for cell lysis to occur, the permeability barrier, which includes
the cytoplasmic membrane, of the E. coli cells needs to be compromised. Since this
membrane is located underneath the cell surface, it is difficult to visualize its disruption.
So, in our study, we examined their interactions with unilamellar vesicles with lipid
compositions mimicking those of mammalian or bacterial membranes. The behavior of
the anionic CPE, PPE-SO32- (Scheme 1.3), was also studied. We employed fluorescent
dye release assays to study the interaction of CPEs and OPEs with model membranes.6
As part of our investigation of the structure-function relationship of the CPEs and OPEs,
a series of CPEs and OPEs with the same backbones but a range of different numbers of
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repeat units (n) with n varying from 1 to 49, or chain lengths, were also synthesized.8 We
used model phospholipid membranes composed of DOPG/DOPE or E. coli lipid extracts
as alternatives in this study, both of which are routinely used as models of the E. coli
plasma membrane.9 We have investigated membrane binding and perturbation activities
of the CPE and OPE compounds in the dark. Morphological changes induced by CPE and
OPE compounds were characterized by fluorescence imaging of single giant vesicles and
cryo-TEM imaging of large unilamellar vesicles (LUVs). Molecular level changes to
bilayer lipid membrane structure were determined by small angle X-ray scattering (SAXS)
and solid-state NMR (SS-NMR) experiments.
3.1.2 Introduction to the models for membrane disruption by AMPs
The design of the synthetic antimicrobial agents was partly inspired by the naturally
occurring antimicrobial peptides (AMPs) that function as a part of innate immunity in
virtually all-living organisms.10-11 Although the size, sequence, and conformation of
AMPs vary substantially, most of these peptides are cationic and amphiphilic.3 AMPs
have been extensively studied during the past 30 years by a wide range of techniques to
examine the mechanisms of AMP’s antimicrobial activity. It is now generally accepted
that the bacterial cytoplasm membrane is one of the AMP’s main targets. The ability of
AMPs to disrupt lipid membranes has been well-documented and remains an active
research area.1, 5 The common cationic and amphiphilic properties shared by both AMPs
and the CPEs/OPEs are expected to give rise to the same chemical and physical driving
forces for lipid membrane binding and disruption. It is thus useful to consider CPE/OPE
– membrane interactions in the context of known membrane disruption models of AMPs
(Figure 3.1).12 We briefly review the membrane action models of AMPs here as these
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models have been discussed in more detail elsewhere.

Figure 3.1. Prevailing models of AMP-membrane interactions.
*The differently colored lipid headgroups represent different charges in Figure 3.1E.
3.1.2.1 Barrel-Stave pore model
In this model, the AMPs first attach to the lipid membrane surface with their long axis
parallel to the membrane surface (Figure 3.1A). As the local concentration of the peptide
increases, the peptides adopt a more ordered conformation and cooperatively insert into
the membrane. As a result, permanent transmembrane pores are formed by the alignment
of the hydrophobic region of the peptides with the hydrophobic core of the lipid bilayer,
where the hydrophilic region of the peptide forms the interior of the transmembrane
pore.2, 4 Thus, the formation of barrel-stave pores requires precise alignment of facial
amphipathicity and hydrophobic matching of the AMPs with the bilayer. Additionally
cooperative and specific peptide-peptide interactions are required. It has been shown that
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transmembrane pores induced by the AMP alamethicin are consistent with the barrelstave model.13-14
3.1.2.2 Toroidal-Pore model
In this model, the membrane bound AMPs insert into the lipid bilayer and force the
outer leaflet to bend continuously to fuse with the inner leaflet (Figure 3.1B). As a result,
somewhat reversible transmembrane pores are formed by both the hydrophilic peptide
regions and lipid head groups.3 In this case, the peptide does not need to span the entire
bilayer – smaller peptides can also induce and stabilize toroidal-pores. The AMP Melittin
has been found to induce toroidal-pores in model lipid membranes.15
3.1.2.3 Carpet and detergent-like models
In addition to the above two pore-forming models, AMPs can also permeabilize lipid
membranes through non-pore mechanisms. In the carpet model, the peptides accumulate
extensively on the outer leaflet of the lipid bilayer, inducing the expansion of the outer
leaflet and causing a strain between the two leaflets of the membrane (Figure 3.1C). At
local peptide concentrations above a threshold level, the strain caused by the peptides will
be released through the collapse of the lipid membrane.16 Some peptides may selfaggregate into micelles in aqueous solutions.17 According to the detergent-like model, the
peptide micelles may interact with the lipid bilayer and remove lipid molecules, which
result in the catastrophic collapse of the membrane (Figure 3.1D). The peptide micelles
could also insert into the lipid bilayer, increasing the transient membrane permeability.
Short peptides which cannot span the lipid bilayer can still permeabilize the membrane
through the non-pore models. Cecropin P1 and Warnericin RK are believed to
disintegrate lipid membranes through these non-pore models.18-19
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3.1.2.4 Lipid clustering model
Many bacterial cytoplasm membranes are composed of both zwitterionic and anionic
lipids and the lipids are not distributed uniformly. Fishov and coworkers have shown that
some lipid domains are enriched in a specific type of lipid in E. coli cell membranes.20
Therefore, the cationic AMPs attached to membranes may cluster anionic lipids and
induce lipid phase separation in the bacterial membrane (Figure 3.1E). This AMP-lipid
interaction may change lipid lateral packing and increase membrane permeability where
leakage of cell content could occur at phase boundary defects.21
3.1.2.5 Interfacial activity model
Based on an extensive study of vesicle perturbation assay results, Wimley proposed
the interfacial activity model to explain the membrane activity of AMPs.4 It is frequently
observed for many AMPs that upon adding the peptides to a homogeneous dye-loaded
vesicle suspension, dye release occurs instantly and then plateaus within several minutes
to levels lower than anticipated for complete dye release. This puzzling phenomenon is
commonly explained as the “all-or-none” mechanism, where a fraction of vesicles
releases all of the dye and the rest releases none. Numerical simulations show that if the
AMPs are truly pore-forming molecules, complete dye release should occur within a very
short time period (less than 1 second). Taking these experimental and computational
results together, Wimley concluded that most AMPs may not induce true permanent
pores in the lipid membrane and that the observed partial dye release may result from
AMP induced transient membrane permeability changes, vesicle fusion, or vesicle
aggregation. This model emphasizes the “imperfect” amphiphilic properties of AMPs,
which provides them with the ability to interact with and reorganize the lipid packing of
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the interfacial region of the bilayer. The peptides may also translocate across the
membrane and in the process disrupt lipid organization and cause toxicity by inducing the
release of cell content.
Since the interactions of AMPs with lipid membranes are very complex and different
AMPs may interact with the membranes through different mechanisms, none of the
above models adequately explains all of the observed phenomena. But the models
provide a good basis for interpreting the membrane activity of AMPs as well as other
membrane active agents. It is important to note that aside from the properties of AMPs
described above, a number of other parameters can significantly influence AMP’s
membrane perturbation mechanisms, including membrane composition, peptide to lipid
molar ratio, temperature and solvent conditions.4, 13
3.2 Results and Discussion
3.2.1 Interaction of the CPEs and OPEs with large unilamellar vesicles (LUV)
It is widely accepted that the AMPs and their synthetic mimics mainly target the lipid
bilayer of the cell membrane.3 The phospholipid compositions of bacterial cell
membranes and mammalian cell membranes are very different.22-23 The principal
phospholipid components in mammalian cell membranes are phosphatidylcholine (PC),
phosphatidylethanolamine (PE), cholesterol, and sphingomyelin.7 Human erythrocyte
cells contain mostly PC and 5-10% of negatively charged phosphatidylserine (PS) lipids.
Because of the asymmetric distribution of erythrocyte membrane lipids, more than 95%
of PS lipids reside on the inner leaflet of the membrane. Thus, the outer leaflet of the
mammalian membrane is near neutral.24 On the other hand, the dominant lipids in the
bacterial

cytoplasmic

membrane

are

phosphatidylglycerol
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(PG),

PE,

and

diphosphatidylglycerol. Most Gram-negative bacterial membranes, including E. coli,
contain 60-70% PE and 20-30% PG. As a result, the bacterial membrane is highly
negatively charged. Based on the differences in lipid composition between mammalian
and bacterial membranes, three vesicle compositions were studied (Table 3.1). The
membrane perturbation activities of the CPE/OPE used in this report were evaluated by
fluorescein release assays (Figures 3.2, 3.3 and 3.4).
Table 3.1. Vesicle abbreviations and corresponding compositions and sizes.

vesicles
V- 1
V- 2
V- 3

lipid
composition
DOPC/cholesterol 67/33
DOPG/DOPE 20/80
E. coli Total Lipid

hydrodynamic
radius (nm)
56±5
58±4
61±2

net surface
charge
neutral
negative
negative

Figure 3.2. Fluorescein leakage profiles from DOPC/cholesterol (67/33) vesicles with the
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addition of a CPE or OPE in buffer A, at room temperature. (Excitation wavelength: 485
nm) Fluorescence from vesicles incubated alone was subtracted.
3.2.1.1 Interaction with mammalian membrane mimic
V-1, composed of PC lipids and cholesterol, is used as a model for mammalian cell
membranes. Only PPE-DABCO, EO-OPE-1(C3) and EO-OPE-1(Th) caused measurable
membrane disruption against V-1 (Figure 3.2). All other CPE and OPE are inactive.
(Note: “inactive” and “no release” refer to no dye release in excess to that of vesicles
incubated alone through the entire incubation period).

Figure 3.3. Fluorescein leakge profiles from DOPG/DOPE (20/80) mixed vesicles with
the addition of a CPE or OPE in buffer A, at room temperature. (Excitation wavelength:
485 nm) Fluorescence from vesicles incubated alone was subtracted.
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Figure 3.4. Fluorescein leakage profiles from E. coli total lipid vesicles with the addition
of CPE or OPE in buffer A, at room temperature. (Excitation wavelength: 485 nm)
Fluorescence from vesicles incubated alone was subtracted.
3.2.1.2 Interaction with bacteria membrane mimics
V-2, composed of DOPG and DOPE, is used as a model for bacterial membranes.
Most of the cationic CPE/OPE show good activity against V-2 (Figure 3.3). Specifically,
PPE-NMe3-OR8, PPE-DABCO and EO-OPE-1(C3) induce approximately 20% dye
release. PPE-NMe3-Th, OPE-2 and 3 and the three S-OPE-n oligomers cause ~ 10%
release. In contrast, the anionic PPE-SO32- and OPE-1, the shortest molecule tested
(based on the distance along the long molecular axis), are inactive. V-3, made from E.
coli total lipid extract, was used as a better mimic of the bacterial membrane. Dye release
of the V-3 vesicles induced by CPE/OPE are comparable to the leakage induced in V-2
vesicles (Figure 3.4). PPE-DABCO and OPE-3 were slightly more effective in inducing
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leakage in V-3 vesicles compared to V-2, and EO-OPE-1(C3) and EO-OPE-1(Th) caused
a similar amount of dye leakage in V-2 and V-3. However, S-OPE-n caused a somewhat
lower dye leakage in V-3 vesicles compared to V-2. Notably, OPE-1 and PPE-SO32- are
still inactive against V-3 vesicles. It is worth noting that the active CPE/OPE exhibit
concentration-dependent membrane disruption against V-3; at higher CPE/OPE:lipid
ratios, higher levels of dye release were observed (data not shown).
3.2.1.3 Summary of CPE/OPE interaction with model membranes
The cationic CPE and OPE used in this study possess significant structural diversity,
but most of them show similar membrane selectivity and, sometimes, even similar
membrane perturbation ability. Generally, most of the CPE/OPE are inactive against the
mammalian cell membrane model V-1 and can induce significant dye leakage from
bacterial membrane models V-2 and V-3. PPE-DABCO, EO-OPE-1(C3) and EO-OPE1(Th) interact with V-1 in a different way from other CPE/OPE. They can perturb V-1
and induce the release of the entrapped dye. One possible reason for PPE-DABCO’s poor
membrane selectivity could be the high positive charge density on its side chains, which
endows PPE-DABCO with the ability to disrupt vesicles composed of zwitterionic lipids.
In addition, the hydrophobic alkyl portion of PPE-DABCO’s side chains can facilitate
their hydrophobic interactions with lipid acyl tails in a similar way to the interaction of
detergents with lipids.25 Our previous work demonstrated that PPE-DABCO does not
incorporate in the lipid bilayer rapidly or efficiently.26 Therefore, it is reasonable to
attribute PPE-DABCO’s high membrane perturbation activity to the unique properties of
its side chains. Meanwhile, the most important structural feature of EO-OPE-1(C3) and
EO-OPE-1(Th) is their linear conformation (no side-chains on the backbones), which
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should permit them to easily penetrate into the lipid bilayer. The estimated molecular
lengths of EO-OPE-1(C3) and EO-OPE-1(Th) (the distance between the two nitrogen
atoms within the terminal quaternary amine groups) are comparable with the lipid bilayer
thickness.27 It is expected that these two molecules can easily coordinate electrostatic and
hydrophobic interactions with the lipid bilayer and therefore can disrupt V-1 more easily
than OPE-n or S-OPE-n. It is worth noting that EO-OPE-1(C3), should have a more
linear conformation than its thiophene-substituted counterpart, EO-OPE-1(Th), which
may account for its higher membrane disrupting activity against all the vesicles tested.
On the other hand, only PPE-SO32- and OPE-1 are inactive against bacterial membrane
mimics V-2 and V-3. The inactivity of PPE-SO32- vs. V-1 and V-3 is attributed to the
anionic polymer’s inability to associate with the negatively charged membrane due to
electrostatic repulsion. Therefore no leakage was observed. Several models, for example
“barrel-stave”, “toroidal pore” and “carpet” (figure 3.1), have been proposed to explain
the antimicrobial mechanism of antimicrobial peptides.3 Furthermore, it has been
assumed that only peptides long enough to span the membrane are able to form stable
pores.28 Of the CPE and OPE compounds studied here, only OPE-1 is shorter than the
hydrophobic thickness of the lipid bilayer,27 which may be a cause of its inactivity.
The OPE-n and S-OPE-n show size-dependent membrane perturbation against V-2 and
V-3. The longer oligomers exhibit stronger activity than the smaller counterparts and this
trend correlates with their biocidal activities in the dark. Tew and co-workers observed
that PE lipids facilitate dye leakage due to their negative curvature, which renders
transmembrane pore formation energetically more favorable.9 A similar phenomenon was
observed in this study. When DOPE in V-2 was replaced with DOPC, most of the
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CPE/OPE, except OPE-1 and PPE-SO32-, exhibited much lower membrane disruption
activity compared to V-2, one representative example is OPE-3 could induce 10% release
of the entrapped fluorescein from V-2 (Figure 3.3B), however, it was almost inactive
against the vesicle made by DOPG/DOPC (20/80) under the same condition.
Photophysical studies of the interaction of CPE with different vesicles have been
previously reported.26,

29

It is noteworthy that when mixing OPE-n or S-OPE-n with

different vesicles, the fluorescence intensities of these oligomers increase remarkably.
Figure 3.5 shows a representative set of fluorescence data. The most pronounced change
in these spectra is the large enhancement of fluorescence intensity, which suggests that
the microenvironment of the oligomers has substantially changed from an aqueous to a
hydrophobic environment after the addition of vesicles.30-31 Moreover, fluorescence
increase occurred immediately after mixing the oligomers with vesicles (data not shown).
In addition, DLS data show that mixing V-1 and V-3 vesicles with OPE-n results in 2-3
nm increase in the vesicle diameters (data not shown). Taken together, it is reasonable to
assume that the active CPE/OPE are first absorbed onto the negatively charged vesicle
surface and then spontaneously reorient to create membrane defects or transmembrane
pores.
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Figure 3.5. Fluorescence emission spectra of OPE-2 and its mixtures with different
vesicles in buffer A, at room temperature. (Excitation wavelength: 375 nm)
As shown in Figures 3.2, 3.3 and 3.4, the partial release of the entrapped dye from
different vesicles upon mixing with CPE/OPE is a fast process. Like antimicrobial
peptides, it is reasonable to postulate that these CPE/OPE can create a stress on the
membrane and induce pore formation either by increasing membrane tension and/or
reducing membrane line tension.32-33 The entrapped dye molecules are expelled through
the pore due to the membrane tension and chemical potential difference of the dye inside
and outside the vesicles. In addition, most of the dye release profiles level off within 10
minutes of mixing and the extent of dye release is much less than 100%. This leveling off
is a common phenomenon that has been reported for most antimicrobial agents and we
hypothesize that this could be attributed to two possible causes. First, the fast release of
the entrapped dye molecules relieves the membrane tension, and at the same time, line
tension at the pore’s edge drives the closure of the pores, resulting in the self-healing of
the vesicles.34-35 Another possible cause is that the leakage process follows an “all-ornone” mechanism36 caused by the non-uniform distribution of CPE/OPE with vesicles,
where only when the amount of the attached CPE/OPE to a vesicle is higher than a
threshold level, pores form and the fast and complete release of the entrapped dye occurs.
However, below the threshold, the attached CPE/OPE can not cooperate efficiently to
create membrane defects or pores for dye release.
3.2.1.4 Conclusion
Results from our dye release experiments show that most CPE and OPE materials used
in this study selectively interact with specific types of membrane lipids. For the polymer
series, the functional groups on the side chains dominate their membrane perturbation
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activity. Specifically, the high charge density and hydrophobic alkyl chains of PPEDABCO’s side chains give rise to the polymer’s high perturbation activity against all the
vesicles used. Not surprisingly, PPE-DABCO also has poor membrane selectivity. For
the three oligomers studied, molecular length greatly influences their interactions with
lipid bilayers. OPE-n and S-OPE-n exhibit size-dependent activity against bacterial
membrane mimics, where longer oligomers exhibit higher activity than their smaller
counterparts. EO-OPE, the oligomers without side chains, exhibit high membrane
perturbation activity and poor selectivity. These results give us insights into the
relationship between molecular structure and membrane perturbation ability of biocidal
CPE and OPE. The observation that specific oligomers and polymers have high
selectivity towards model bacterial membranes and little activity towards model
mammalian membranes indicates these materials may be efficient and yet non toxic
antimicrobials.
3.2.2 Chain length effect of the CPEs and OPEs on their membrane perturbation
activities
Over the last decade, new synthetic amphiphilic antimicrobial agents with tunable
structure have been reported.24, 37 One of the most remarkable features of these synthetic
compounds is their high toxicity to bacterial cells and low hemolytic activity against
human red blood cells. In addition, the antimicrobial ability of these molecules is related
to their insertion or perturbation ability against bacterial cell wall and membranes. Herein,
photophysical investigation, dye release assays and monolayer insertion assays were used
to explore the membrane perturbation ability of a series of CPEs and OPEs that differ in
their number of repeat units.
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3.2.2.1 Photophysical investigation
Since the photophysical properties of the CPEs and OPEs is highly dependent on their
solution microenvironment,1, 3 a set of photophysical measurements were obtained to
elucidate the changes of the microenvironments of the CPEs and OPEs when they come
into contact with lipid vesicles composed of either DOPC lipids (a mammalian cell
membrane mimic) or E. coli total lipid extract (a bacterial cell membrane mimic). We
have shown earlier that in aqueous solutions the OPEs are monomeric in the µM range.38
In contrast, the CPEs readily aggregate in aqueous solutions via intra- or inter-chain
stacking of the conjugated backbone and this type of aggregation drastically decreases the
fluorescence emission intensity of the CPEs compared to OPEs.1 Thus, fluorescence
emission intensities of the compounds were measured to probe changes in the
aggregation state of the compounds in the presence of different lipid vesicles.
Absorbance measurements were made to probe changes in conjugation length, or
segment chromophores,39 of the compounds where red shifts indicate increases of the
conjugation length in the molecular backbone.
All CPEs and OPEs exhibit similar spectral changes, including absorbance spectral
shifts and increases in emission intensity, upon incubation with the two types vesicles;
Figure 3.6 shows a set of representative absorbance and emission spectra for oligomeric
S-OPE-3 and polymeric PPE-NMe3-7-COOEt alone or incubated with the two different
vesicles. As shown, absorbance maxima of both OPEs and CPEs undergo red-shifts at
different extents, with the E. coli total lipids inducing the largest changes (Figures 3.6A
and 3.6C). The emission intensity of the OPEs and CPEs significantly increased in the
presence of lipid vesicles and the E. coli total lipids again induced the largest increases.
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Parameters obtained from the photophysical characterizations of the CPE and OPE
compounds are summarized in Table 3.2. Our data show that the maximum absorbance
wavelengths of OPEs in water increased with chain length while the maximum
absorbance wavelengths of the CPEs did not exhibit such a trend (Table 3.2). This is
probably due to the ability of the long chains of the CPEs, which are longer than the
average conjugation length of the segment chromophores39 within the backbone, to form
intra- and/or inter-chain aggregates.40-42
As shown in Table 3.2 and Figure 3.6, when CPEs and OPEs are mixed with different
model membranes, their photophysical properties change drastically. Specifically, E.coli
total lipid extract vesicles induced significant red-shifts in the absorbance maxima for all
CPE and OPEs compounds, while DOPC vesicles induced little or no change. The redshifts could be partly due to segment planarization of the CPEs or OPEs from their
interactions with the E. coli lipid membrane, thus extending the conjugation length of the
CPEs and OPEs along their backbones.43-45 Moreover, the addition of lipid vesicles
greatly increases the fluorescence emission intensity of both the CPEs and OPEs (Figure
3.6), suggesting that when exposed to lipid membranes, the microenvironment of CPEs
and OPEs changed from an aqueous to a hydrophobic environment and consequently,
nonradiative processes have been significantly reduced.1, 3 Meanwhile, the lipid vesicles
induced blue-shifts in the CPEs’ emission spectra (Figure 3.6D and Table 3.2), implying
that the conformation of the CPEs may have changed from an aggregated state to a more
extended state and that this conformational change was facilitated by the lipid
membranes.46-49 Overall, changes in spectral characteristics induced by the E. coli lipid
vesicles were significantly larger than those induced by the mammalian-mimicking

55

vesicles, indicating that the interactions of the CPE and OPE compounds with E. coli
lipid vesicles were stronger and more extensive compared to the mammalian membrane
mimic.
Our results indicate that the amphiphilic CPEs and OPEs bind to lipid vesicles readily
and upon binding, properties such as conjugation length and aggregation state of the
compounds change. The binding of the CPEs and OPEs to the lipid vesicles membranes
was further confirmed by increases in Rh values of the vesicles after the addition of a
CPE or OPE to the vesicles, for example, Rh of E. coli vesicles increased from 67±3 nm
to 75±2 and 91±3 nm upon the addition of S-OPE-2(COOEt) and PPE-NME3-20COOEt, respectively. The binding of the antimicrobial agents to vesicles have been
shown to be in part driven by electrostatic interactions. Favorable entropy increases by
the release of interfacial water through the binding of CPE or OPE to membranes may
also contribute to their high affinity towards membranes.43
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Figure 3.6. Absorbance (A, C) and fluorescence emission (B, D) spectra of oligomeric SOPE-3(COOEt) and polymeric PPE-NMe3-7-COOEt and their mixtures with different
lipid vesicles in water at room temperature. The excitation wavelengths for S-OPE3(COOEt) and PPE-NMe3-7-COOEt are 383 nm and 401 nm respectively.
Table 3.2. Photophysical characterization of the CPEs and OPEs in different solutions at
room temperature. The maximum absorbance wavelength of each compound in water
was selected as the excitation wavelength for all the corresponding emission spectra.
DOPC and E. coli total lipid concentrations were 0.2 mM and 0.2 mg/ml, respectively.
Lipid to CPE or OPE ratio was 50:1.
Maximum Absorbance
Maximum Emission
Wavelength (nm)
Wavelength (nm)
Antimicrobial
Agent
H2 O
E. coli
DOPC
H2 O
E. coli
DOPC
S-OPE-1(COOEt)

359

370

360

433

436

434

S-OPE-2(COOEt)

377

395

379

437

436

434

S-OPE-3(COOEt)

383

399

383

431

436

436
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PPE-NMe3-7-COOEt

401

409

401

484*

443

443

PPE-NMe3-20-COOEt

404

415

406

479*

444

445

PPE-NMe3-49-COOEt

404

415

406

486*

443

443

*The emission spectra of the CPEs in water were broad and flat.
3.2.2.2 Disruption of mammalian and bacterial membrane mimicking vesicles
Vesicles of two different lipid compositions were prepared to mimic mammalian and
bacterial cell membranes40 (Table 3.3). V-1, composed of PC lipids and cholesterol, is
used as a model for mammalian cell membranes. Figure 3.7 shows the fluorescein
leakage profiles from V-1 vesicles incubated with the different CPEs and OPEs. In all
cases, no dye release in excess to that of vesicles incubated alone is observed during the
incubation period. Clearly, the antimicrobial molecules in the concentration range tested
are inactive at disrupting the mammalian membrane mimic.
Table 3.3. Vesicle abbreviations and their corresponding compositions, sizes, and overall
charges.
Vesicles
Lipid
Hydrodynamic Net Surface
Composition
Radius (nm)
Charge
V-1
67:33 DOPC:cholesterol
56±5
Neutral
V-2
E. coli Total Lipid
61±2
Negative
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Figure 3.7. Fluorescein leakage profiles from DOPC:cholesterol (67:33) vesicles (V-1)
with the addition of a CPE or an OPE in buffer A at room temperature
(Excitation/Emission wavelength: 485/520 nm). Fluorescence from vesicles incubated
alone was subtracted.
Vesicles V-2, made from E. coli total lipid extract, were used as a model for the
bacterial membrane. As shown in Figure 3.8, all CPEs and OPEs tested induced dye
release, indicative of membrane disruption against V-2 vesicles. Moreover, the extent of
dye release was highly dependent on the molecular size and concentration of OPEs and
CPEs (Figure 3.8). Increasing the chain length of the oligomers enhanced their membrane
perturbation activity (Figure 3.8A and B). In contrast, the polymers showed the opposite
trend -- increasing the number of repeat units decreased the polymer’s membrane
perturbation ability (Figure 3.8C and D).
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Figure 3.8. Fluorescein leakage profiles from E. coli total lipid vesicles (V-2) with the
addition of CPE or OPE in buffer A, at room temperature (Excitation/Emission
wavelength: 485/520 nm). Fluorescence from vesicles incubated alone was subtracted.
The results from dye leakage assays show that the CPEs and OPEs selectively perturb
the bacterial membranes and that the membrane disruption ability is highly dependent on
chain length. For the oligomers tested, increasing the chain length enhanced their ability
to incorporate or perturb lipid membranes that led to the leakage of dye molecules from
inside the vesicles to the bulk phase. In contrast, increasing the chain length of polymers
reduced their membrane perturbation ability probably by enhancing their tendency to
form aggregates via intra- and/or interchain stacking. As a result, the effective
concentration of the polymers that could interact with the lipid vesicles is reduced.
Additionally, formation of aggregates can also reduce the polymer’s cooperativity in
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inducing membrane surface defects, which may proceed by a highly synergistic
mechansim.36
3.2.2.3 Lipid monolayer insertion assays
Monolayer insertion assays are often used to evaluate the interaction and the
membrane insertion ability of naturally occurring antimicrobial peptides and synthetic
biocidal agents.50 In the current study, insertion assays of CPEs and OPEs into lipid
monolayers at the air/water interface composed of DPPG and DPPE were carried out at
constant surface pressure to evaluate the effect of chain length on their membrane
insertion ability. DPPE is zwitterionic and was used instead of DOPC lipids for insertion
assays because DPPE forms a more stable monolayer. Moreover, since DPPE and DPPG
monolayers are both in the lipid-condensed phase under the experimental conditions,
where as DOPC would be in a liquid-expanded phase, the effect of membrane fluidity or
lipid packing will have minimal influence on insertion results.
Figure 3.9 shows insertion isotherms of the CPEs and OPEs into DPPG monolayers
held at 30 mN/m on water at room temperature. Note that CPEs and OPEs alone did not
give rise to any surface pressure at the air-water interface (data not shown). Insertion
results shown in Figure 3.9 are thus due to favorable interactions between DPPG
monolayer and the CPEs or OPEs. Consistent with results obtained from dye leakage
assays, the CPEs and OPEs show repeat unit dependent monolayer insertion ability.
Specifically, increasing chain length increased the extent of insertion of OPE oligomers,
while the opposite trend is observed for CPEs. The longest CPE, PPE-NMe3-49-COOEt,
did not insert into the DPPG monolayer at 0.1 µM. However, increasing the concentration
to 0.5 µM resulted in extensive insertion (data not shown). In contrast, none of the CPEs
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or OPEs tested inserted into the lipid monolayers composed of the zwitterionic DPPE
lipids (data not shown). Taken together, results obtained from lipid monolayer insertion
assays provide additional evidence for the size-dependent membrane perturbation ability
of CPEs and OPEs and their selectivity towards negatively charged membranes.

Figure 3.9. Insertion profiles of CPEs (0.1µM) or OPEs (0.1µM) into DPPG monolayers
held at 30 mN/m on water at room temperature.
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3.2.2.4 Conclusions
Our study clearly demonstrates that cationic CPEs and OPEs exhibit affinity towards
both mammalian and bacterial-mimicking lipid membranes and that they selectively
perturb bacterial model membranes. The dye release assays reveal that all CPEs and
OPEs are inactive against model mammalian membranes in the concentration ranges
tested. However, they show significant membrane perturbation activity against model
bacterial membranes and that they readily insert into negatively charged lipid monolayers
at the air/water interface. Moreover, the materials exhibit chain-length dependent
membrane perturbation ability where increasing chain length increased the ability of the
oligomers to incorporate and perturb membranes and the reverse trend was observed for
the polymers. Taken together, there might be an optimum chain-length for these PPEbased antimicrobial compounds that corresponds to the highest membrane perturbation
efficiency. The results of current study will serve as a guide to design more efficient and
nontoxic materials resistant to bacteria growth and biofilm formation.
3.2.3 Visualization of the membrane failure induced by the CPEs and OPEs and
their membrane perturbation mechanisms
3.2.3.1 Visualization of the interactions with giant vesicles
The membrane perturbation actions of OPE-1 and EO-OPE-1(C3) were visualized and
compared by imaging single giant vesicles (Figure 3.10). Upon the addition of OPE-1 to
giant vesicles composed of E. coli total lipids, the vesicle disintegrated and disappeared
quickly. Thus, OPE-1 efficiently incorporated into lipid bilayer and may induce lipid
phase separation followed by the lysis of the vesicle structure, which may undergo the
carpet or detergent-like membrane destabilizing model.12 EO-OPE-1(C3) can also
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dramatically change the morphology of the lipid vesicle. However, the residual lipid-OPE
structure was still observable and no further morphology changes or vesicle
disintegration occurred even upon prolonged observation (image not shown). It is worth
noting that as a control, the addition of 10 mM HEPES buffer alone did not cause any
visible damage to the vesicle (data not shown). Quantitatively, EO-OPE-1(C3) possesses
much higher membrane perturbation ability against both model bacterial and mammalian
cell membranes than OPE-1.6 Herein, the single giant vesicle assay is employed as a
qualitative measurement to observe the membrane disruption actions for the OPEs used
for the current study. The actual concentration of the OPEs interacting with the vesicle is
difficult to determine, but is estimated to be much lower than 50 µg/ml (see Experimental
Methods).

Figure 3.10. Time lapse fluorescence microscopy images showing the damage of giant
vesicle caused by the addition of OPE-1 (A) and EO-OPE-1(C3) (B) at room temperature.
The vesicle is composed by E. coli total lipid and labeled with DMPE-Rh and Biotin-
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PEG-DSPE (0.5% and 2.5% molar percentage respectively). The elapsed time after the
addition of antimicrobial agent is labeled for each image.

Figure 3.11. Time lapse fluorescence microscopy images showing the damage of a giant
vesicle caused by the addition of PPE-DABCO (10 µg/mL) (A) and OPE-3 (50 µg/mL)
(B) at room temperature. The vesicle is composed of E. coli total lipids and labeled with
0.5 mol% of DMPE-Rh for imaging and 2.5 mol% of Biotin-PEG-DSPE for localization
to the slide surface.23 The elapsed time after the addition of the antimicrobial agent is
labeled in each image.
The same technique has also been used to image membrane morphological changes
induced by polymeric PPE-DABCO and oligomeric OPE-3. As shown in Figure 3.11A,
upon the addition of PPE-DABCO to a giant vesicle composed of E. coli total lipids, the
vesicle appeared relatively intact until it suddenly ruptured 55 – 56 s after PPE-DABCO
addition and then mostly disappeared at around 58 s. In contrast, after the addition of
OPE-3, the giant vesicle immediately started to change, shrinking in size and becoming
diffuse and eventually losing its structural integrity by 27 s (Figure 3.11B). During the
process, the well-defined and bright lipid membrane became amorphous in shape and
inhomogeneous in brightness, indicating that lipid-OPE-3 complexes may have been
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formed (Figure 3.11B). These images show that both PPE-DABCO and OPE-3 exhibit
strong disruptive activities against the model bacterial membrane and that the two
compounds cause membrane disruptions via different mechanisms. However, this assay
does not give further insights into the molecular scale structural transformations of the
bilayer induced by the two biocidal compounds.
3.2.3.2 Cryo-TEM imaging
To more closely examine membrane changes induced by the biocidal compounds,
cryo-TEM was used to image LUVs before and after exposure to two different OPEs,
OPE-2 and EO-OPE-1(C3). The cryo-TEM image of LUVs (Figure 3.12A) showed
largely round vesicles with diameters of around 100 nm. The addition of OPE-2 appeared
to induce vesicle fusion, resulting in the formation of many dumbbell-like bilayer
structures (Figure 3.12B). The vesicle fusion process may proceed by the attachment of
OPE-2 to vesicle surface, thereby changing its charge distribution and reducing vesiclevesicle electrostatic repulsion, resulting in vesicle fusion. Similarly, the addition of EOOPE-1(C3) to vesicles also caused vesicle fusion (Figure 3.12C). In addition, EO-OPE1(C3) induced significant roughness to a number of vesicles (Figure 3.12C and D), which
could be an early stage of membrane failure/collapse. Although cryo-TEM is a powerful
technique in visualizing assemblies of soft biological materials with minimal disturbance
to the sample, as compared to conventional TEM where samples are dried on a substrate,
it does have the limitation that only a very thin section of the samples are visualized.
Structures larger than sample thickness, for example, visible aggregates of OPEmembrane complexes formed during the experiment, were not imaged. As such, cryoTEM imaging does not capture the full range of OPE and CPE-induced membrane
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changes.

Figure 3.12. Cryo-TEM micrographs of DOPG/DOPE vesicles (10 mg/mL) alone (A),
incubated with 2.16 mg/mL OPE-2 (B) 1.53 mg/mL EO-OPE-1(C3) (C) for 30 min in the
dark. A closer view for the EO-OPE-1(C3) treated vesicles shown in D. The lipid to OPE
molar ratio is 25:1. The scale bars represent 200 nm.
3.2.3.3 Small angle X-ray scattering
SAXS can resolve Å-scale structural details of ordered lipid phases in bilayer
membranes and has been used to detect the presence of lipid ordered structures in a bulk
background.51 As described above, the potent antimicrobial activity of EO-OPE-1(C3)
stems from its high membrane activity; it is of particular interest to further investigate its
membrane perturbation mechanism by SAXS. In addition to vesicles composed of E. coli
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total lipid extract, vesicles made of 20:80 DOPG:DOPE were also used for the SAXS
assay (see Experimental Methods). For vesicles alone, only one broad peak with low
scattering intensity is detected for each lipid composition (Figure 3.13, red lines), which
suggests the existence of a lamellar phase for the SUVs.52 After exposure to EO-OPE1(C3), scattering profiles of the vesicles dramatically changed. Multiple, new and sharp
scattering peaks are observed in both membrane systems. The peak at q = 0.3296 Å-1 is
due to EO-OPE-1(C3) (data not shown). The peak positions (q values) of the
DOPG:DOPE model membrane exposed to EO-OPE-1 have the characteristic ratio of 1:

3 : 2 : 7 , indicative of an inverted hexagonal phase (Figure 3.13A).53 A similar trend
is observed for the vesicles composed of the more complex E. coli total lipids (Figure
3.13B), although the exact positions of the new peaks deviate from that of an inverted
hexagonal phase and the nature of the new lipid phase at present is unclear. Tew and coworkers have systematically investigated the membrane perturbation activity of a series
of antimicrobial meta-phenylene ethynylene oligomers via SAXS and other
technologies.9, 54 Similar to what we have observed for EO-OPE-1(C3), one of Tew’s
membrane active oligomers, AMO-2, was capable of forming a complex with E. coli
lipid membranes/vesicles and induce a hexagonal structure. The deviation of the SAXS
peak positions from the characteristic inverted hexagonal phase has been attributed to the
complex lipid distribution from the bacterial membrane extracts. As described in the
single giant vesicle imaging section, the EO-OPE-1(C3) and E. coli membrane complex
was not soluble in the aqueous solvent, which also supports the assumption of the
possible formation of hydrophobic inverted hexagonal complex. At the current stage, we
can not rule out the possibility of the formation of other bicontinuous cubic phases for the
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EO-OPE-1(C3) and E. coli membrane complex. However, these changes indicate that the
oligomer is capable of inducing specific structural changes to the lamellar lipid phase.
Wimley proposed the interfacial activity model to explain the membrane activity of
antimicrobial peptides. Based on Wimley’s theory and our previous dye release assays,
OPE-1 and EO-OPE-1(C3) may not be able to induce the formation of permanent
transmembrane pores in lipid vesicles such as barrel stave pores.
We also used SAXS to characterize the effects of oligomeric OPE-2 and polymeric
PPE-Th on lipid membrane structure. After exposure to OPE-2 and PPE-Th, scattering
profiles of the vesicles changed dramatically (Figures 3.13C and D). A number of new
and sharp scattering peaks were observed. The peak positions (q values) of the model
membranes treated by OPE-2 and PPE-Th have the characteristic ratio of 1:2:3:4,
indicative of a new multi-lamellar structure.55 As a control, DMSO, which was used to
increase the solubility of the OPEs, had negligible effect on the membrane structure
(Figure 3.14). Therefore, the emergence of the new peaks due to the formation of
multilamellar structures, were solely caused by the interactions between the CPE and
OPE compounds with the model membrane. The SAXS experiments demonstrate that
both polymeric and oligomeric biocidal compounds are capable of inducing structural
reorganization of the lipid membrane on the molecular scale.
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Figure 3.13. SAXS data for EO-OPE-1(C3) (3.8 mg/ml) complexed with 20:80
DOPG/DOPE (12.5 mg/ml) (A) and EO-OPE-1(C3) (3.8 mg/ml) (B), OPE-2 (5.78
mg/mL) (C) and PPE-Th (2.59 mg/mL) (D) complexed with E. coli total lipid (12.5
mg/mL) model membranes.

Figure 3.14. SAXS data for E. coli total lipid (12.5 mg/ml) model membranes alone and
incubated with DMSO.
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3.2.3.4 31P solid state NMR
In addition to SAXS, 31P SS-NMR spectroscopy was also used to investigate the bulk
phase behavior of model membranes in the presence of increasing amounts of EO-OPE1(C3). In these experiments, the anisotropy (orientation of the phosphate head groups) of
the lipid self-assemblies exhibit distinct NMR line shapes for different phases. The

31

P

NMR signal of the bacterial mimic DOPG/DOPE membrane is characteristic of a
randomly dispersed lipid bilayer (bottom spectrum in Figure 3.15). The addition of 1.5
mg EO-OPE-1(C3) (to 25 mg of lipid) caused a significant decrease in the signal
intensity in the high field and induced an additional peak at the isotropic chemical shift
position, indicating the formation of isotropic non-bilayer phases, such as micelles,
inverted micelles, or various cubic phases.56 With increasing concentrations of EO-OPE1(C3) (2.5-5 mg), the lipid sample showed a single sharp isotropic peak, indicating that
EO-OPE-1(C3) did not induce the formation of new structures other than the isotropic
phases in this concentration range. The addition of Triton X-100, a well-known non-ionic
detergent that is widely used as a lipid membrane solubilizing agent, also gave rise to a
weak isotropic peak, which implies that the two compounds induced similar bulk phase
changes to the lipid membranes (Figure 3.15). SS-NMR data were also collected from
vesicles composed of E. coli total lipid extract. The appearance of non-bilayer phases
caused by the addition of EO-OPE-1(C3) to this model membrane was also observed
(Figure 3.16). However, since the exact composition of the total lipid extract is unknown,
the NMR spectra could not be further resolved.
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Figure 3.15. 31P SS-NMR spectra of 25 mg DOPG/DOPE (molar ration 2:8) model
membranes mixed with various amounts of EO-OPE-1(C3) and 100 mg Triton.

72

Figure 3.16. 31P SS-NMR spectra of 25 mg model membranes made by E. coli lipid
extracts mixed with various amounts of EO-OPE-1(C3).
3.2.3.5 Conclusions
Results from the membrane perturbation study confirm that the CPE and OPE
materials are membrane active and induce membrane changes from morphological to
molecular scale. Giant vesicle imaging shows disintegration of vesicles while cryo-TEM
imaging provided clear evidence of OPE and CPE-induced membrane fusion and
roughening. Our results also provide a molecular scale structural basis for the observed
membrane morphological and functional changes (i.e., membrane permeabilization from
vesicle release studies). The CPE and OPE materials can disrupt the lamellar membrane
structure and induce the formation of non-bilayer structures, such as hexagonal and cubic
phases and micellar structures. It is important to note that, due to different sample
requirements by the different analytical methods, such as concentration, sample thickness,
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hydration state, and lamellarity, each method probes the interactions between the biocidal
compounds and model membranes under a specific set of conditions that give insights to
specific aspects of biocide-induced membrane perturbation.146 Recent simulation studies
show that OPE-3 with ionic side groups may strongly associate with the model bacterial
membrane and disrupt the bilayer by the formation of water channels (Figure 3.17A).57
However, EO-OPE-1(C3) with the ionic groups at the ends of the molecule is unlikely to
form transmembrane, water-permeable pores in the same membrane (Figure 3.17B).58 It
has been suggested that these PPE-based materials most likely disrupt the lipid membrane
via carpet or detergent-like mechanisms. Our multi-scale characterization of the dark
membrane perturbation activity of the CPEs and OPEs using model E. coli plasma
membranes so far support a carpet or detergent-like mechanism by which these
antimicrobial compounds induce membrane collapse and phase transitions.
Most of the naturally occurring antimicrobial peptides (AMPs) are cationic and
amphiphilic, and it is widely accepted that the bacterial cytoplasmic membrane is one of
the primary targets of the AMPs. Several models have been proposed to explain the
membrane perturbation mechanisms of the AMPs.20 While the membrane disruption
models are conceptually useful, many fundamental aspects about the membrane activity
of AMPs remain unclear.29 Considering the common cationic and amphiphilic nature
shared by both CPEs/OPEs and AMPs, these materials may bind and disrupt the lipid
membrane with similar chemical and physical driving forces. Although multiple
biophysical and biochemical techniques have been used to study the structural and
functional changes model lipid membranes undergo when exposed to CPEs and OPEs, a
fundamental

molecular-level

mechanistic
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understanding

of

the

membrane

permeabilization actions of the CPE and OPE materials is still lacking. “The Blindfolded
Men and the Elephant” story has been used to describe the problems in understanding the
antimicrobial mechanisms of the AMPs.59 Just like the six blindfolded people “observing”
the elephant, each technique used in our studies only reports one aspect of the membrane
perturbation mechanism(s) of the PPE-based materials under a specific set of
experimental conditions.

Figure 3.17. Two different representations of snapshots from simulation studies of the
OPE-DOPG/DOPE membrane interactions (A) Nitrogen atoms in the cationic quaternary
ammonium groups of OPE-3 are illustrated in gray, red, yellow, and purple. The
backbones of the OPE molecules creating the pore are shown in green. Waters are shown
as diffuse blue spheres. Reprinted with permission from ref 57. Copyright 2012 ACS
Publications. (B) The backbones of EO-OPE-1(C3) are shown in orange. Nitrogen atoms
in the cationic quaternary ammonium groups are illustrated in blue. The phosphorus
atoms on the lipid hand groups are shown in tan and pink. Waters are shown in cyan.
Reprinted from ref. 58 with kind permission from Springer Science+Business Media.
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Chapter 4. Interactions with Proteins and Nucleic Acids
4.1 Introduction
In addition to exhibiting biocidal activity against bacteria, the CPEs and OPEs can also
efficiently inactivate the wildtype Sterne strain of Bacillus anthracis spore, yeast spore1
and two model viruses (T4 and MS2 bacteriophages).2 Unlike those of bacteria, the
surfaces of these pathogens are comprised of a significant amount of proteins, implying
that proteins and protein assemblies can also be targets of the CPE and OPE materials.
Moreover, the CPEs and OPEs can create defects on the cell envelope3 and viral capsid,2
which may facilitate their entrance into the cell and viral interior. Once inside, the CPEs
and OPEs can interact and potentially disrupt other (cellular) targets, such as DNA, RNA,
and polysaccharides (cellulose). It is evident that the CPE and OPE materials can induce
damage to multiple cellular targets. Proteins in the cytoplasm are believed to be another
target, particularly for 1O2 generated under UV-irradiation as amino acids are readily
oxidized by 1O2 with a rate constant in the range of 107-108 M-1s-1.4-5 Moreover,
secondary ROS could react with a broader range of targets in the cell, including the DNA
and RNA. The ROS sensitized by the CPE and OPE materials can directly or indirectly
covalently modify biomolecules in the cytoplasm, thereby inducing toxicity. Furthermore,
proteins and nucleic acids are believed the main targets of the singlet oxygen-mediated
damage (Figure 4.1).4
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Figure 4.1. Predicted consumption of 1O2 by intracellular targets calculated using the rate
constant data given in and the average concentration of each component within a typical
leukocyte cell. Reprinted with permission from ref 4.
4.2 Results and Discussion
4.2.1 Interactions with proteins
Since proteins are a key component of biological cells,6 studying their interactions with
CPEs and OPEs will provide further insight into CPEs and OPEs’ toxicity mechanisms.
In this study, the effects of CPEs and OPEs on the secondary structure of three model
proteins, bovine serum albumin (BSA), lysozyme, and cytochrome C were evaluated.
Lysozyme and cytochrome C are well-folded small globular proteins that have been
extensively studied. BSA possesses a high degree of homology with human serum
albumin (HSA).7-8 Serum albumins are abundant in the mammalian circulatory system
and carry out various important physiological functions.9 More important, BSA is a more
hydrophobic protein with high surface activity compared to the highly soluble and
charged lysozyme and cytochrome C, and should serve as a better model for membrane
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proteins. The physicochemical properties of these model proteins are summarized in
Table 4.1.10-12 The addition of CPEs and OPEs did not induce any changes in the CD
spectra of lysozyme or cytochrome C (data not shown), suggesting that no
conformational changes to the native protein structures were induced. This is probably
due to the electrostatic repulsion between the cationic CPEs and OPEs with the two
positively charged proteins (see Table 4.1) that prevented their association. In contrast,
some degree of structural perturbation was observed for BSA incubated with CPEs and
OPEs in the dark (Figures 4.2 and 4.3). In particular, the addition of PPE-Th caused the
most significant loss to the protein’s secondary structures (200-260 nm). Furthermore, the
BSA/PPE-Th mixture is also uniquely CD active in 400-500 nm region, where PPE-Th
absorbs (inset of Figure 4.2). By itself, the PPE-Th polymer is not CD active in this
region (data not shown). PPE-Th is known to be highly lipophilic and this property may
be responsible for its ability to denature the relatively hydrophobic BSA.13 Furthermore,
complexing PPE-Th with BSA render the polymer CD-active, indicating that distinct
structures are formed. PPE-DABCO also induces conformational change in BSA, albeit
to a lesser extent compared to PPE-Th. In contrast, only small conformational changes
are observed when BSA is incubated with the oligomers (Figure 4.3). Although none of
the model proteins used in this study is a bacterial membrane protein, the result can
provide some insights of to the interaction between our antimicrobial compounds and
proteins. When a bacterial cell becomes associated with PPE-Th, one mode of its toxic
pathway may be the denaturation of membrane proteins.
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Figure 4.2. Circular dichroism spectra of BSA (0.1 mg/ml) and its complexes with CPEs
(10 µg/ml) in phosphate buffer at room temperature. CPEs alone do not have any circular
dichroism signal.

Figure 4.3. Circular dichroism spectra of BSA (0.1 mg/ml) along or in the presence of
OPEs (10 µg/ml) in phosphate buffer (2 mM NaH2PO4, 8 mM Na2HPO4, pH 7.4) at room
temperature. OPEs alone do not have any circular dichroism signal.
Table 4.1. Physicochemical properties of model proteins used in this study.
Protein
Isoelectric Point
Net charge*
Molecular Weight (KDa)
Main Secondary Structure

BSA
4.8
66
α-helical

Lysozyme
10.6
+
14
α-helical

Cytochrome C
10~10.5
+
12
α-helical and unordered structure

* Net charge on protein under current experimental conditions.
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4.2.2 Electrophoresis characterization for the DNA and protein damage
We have demonstrated that the CPEs and OPEs can cause severe damage inside the
Gram-negative bacteria in the presence of UV-light.14 To better understand the nature of
the changes, we investigated the effect of the oligomeric EO-OPE-1(C3) under UVirradiation on two classes of potential targets in E. coli, proteins and plasmid DNA. As
shown in Figure 4.4A, SDS-PAGE of E. coli cells under different exposure conditions to
EO-OPE-1(C3) showed no significant differences in the electrophoretic mobilities or
intensities of protein bands from cells treated with EO-OPE-1(C3) in the dark (Lane A2)
or UV-irradiation alone (Lane A3) compared to untreated cells (Lane A1), indicating that
the proteins did not undergo covalent modifications, such as cross linking or degradation.
In contrast, protein bands from E. coli cells incubated with EO-OPE-1(C3) under UVA
irradiation show significantly decreased intensities (Figure 4.4, Lane A4), indicating that
1

O2 and ROS generated by the irradiation of EO-OPE-1(C3) had induced significant

covalent modifications to the proteins that either caused the formation of insoluble
aggregates that are too large to enter the electrophoresis gel or degradation of proteins
into fragments too small to be detected by the technique. Similarly, the ROS sensitized by
EO-OPE-1(C3) caused considerable decreases to the intensities of the E. coli plasmid
DNA bands (Lane B5) compared to untreated cells (Lane B2), whereas the bands
remained relatively unchanged from E. coli cells incubated with EO-OPE-1(C3) for an
hour in the dark (Lane B3) or irradiated for an hour (Lane B4). Cross-linking and
subsequent aggregation are the primary protein chemical degradations induced by 1O2 and
secondary ROS.4 Likewise, 1O2 and secondary ROS could also induce the formation of
covalent DNA-protein complexes.15 However, protein-DNA complexes and aggregates
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may not be soluble in water or identified from electrophoresis. In addition, ROS can also
induce protein backbone fragmentation and DNA cleavage, which may also contribute to
the changes observed in protein and plasmid DNA gel electrophoresis and the toxic
functions of EO-OPE-1(C3). In addition to disrupting membrane lipid bilayer structure,
damage to the proteins in bacterial cytoplasmic membranes by light-induced ROS, which
serve critical functions, also compromise the membrane integrity and promote the release
of cell content as well as the entrance of the CPEs and OPEs.

Figure 4.4. (A) SDS-PAGE gels of the E. coli (4×108 CFU/mL) cells incubated with EOOPE-1(C3) (25 µg/mL) for 1 hour. Lane A1: E. coli in the dark; Lane A2: E. coli
incubated with EO-OPE for 1 hour in the dark; Lane A3: E. coli irradiated with UVA for
1 hour; Lane A4: E. coli incubated with EO-OPE under UVA-irradiation for 1 hour; Lane
A5: Protein ladder. (B) Agarose-gel of the pET-20b plasmid extracted from E. coli
BL21(DE3) (1×108 CFU/mL) incubated with EO-OPE-1(C3) (1 µg/mL) for 1 hour. Lane
B1: DNA ladder; Lane B2: E. coli in the dark; Lane B3: E. coli incubated with EO-OPE
in the dark for 1 hour; Lane B4: E. coli irradiated with UVA for 1 hour; Lane B5: E. coli
incubated with EO-OPE under UVA-irradiation for 1 hour.
4.3 Conclusions
To further investigate the toxicity pathway of the CPEs and OPEs upon their
association to the bacterial surface, we have evaluated whether CPEs and OPEs affect
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model protein structures. Herein, we characterized the effect of CPEs and OPEs on the
conformation of model proteins bovine serum albumin (BSA), lysozyme and Cytochrome
C using circular dichroism. PPE-Th and PPE-DABCO caused the significant losses to the
BSA’s secondary structures. Moreover, under UV-irradiation, all of the tested
antimicrobial compounds can cause damage to the cytoplasm of the Gram-negative E.
coli cells, including oxidative and covalent modifications of proteins and plasmid DNA.
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Chapter 5. Bactericidal Activities of the CPEs and OPEs
5.1 Introduction
Investigations of the biocidal mechanisms of the CPEs and OPEs revealed that these
cationic and amphiphilic compounds are membrane-active, capable of inducing
disruptions to the membrane structure.1 For example, the small oligomeric EO-OPE-1(C3)
(Scheme 1.3) can disrupt model bacterial membranes and induce a phase transition from
a lamellar to a hexagonal phase. In general, these CPE and OPE materials exhibit broad
spectrum and rapid light-enhanced biocidal activities and moderate killing efficiencies in
the dark. Furthermore, both the light-activated and dark biocidal activities of CPEs and
OPEs are believed to be initiated by their interactions with the bacterial outer envelopes.
Therefore, the main focus of the work in this chapter is to understand the lethal effect of
the CPEs and OPEs against bacteria in the dark and under UV-irradiation, which is also a
part of our structure-activity relationship study.
The biocidal activity and selectivity of the CPE, OPE and other antimicrobial
compounds can be related to their membrane perturbation ability. However, for some of
the biocidal materials, their antimicrobial activity may also stem from the interaction with
other bacterial outer envelope components, such as membrane embedded proteins and
lipopolysaccharides (LPS).2-4 In other words, their membrane activity may only partially
account for the antimicrobial ability. Although some insights have been gained about
CPE and OPE’s biocidal and membrane activities, little is known about their mechanism
or mode of binding to the bacterial outer envelope or the subsequent key toxicityinducing events.
Since the cell surface serves as the first point of contact for biocidal agents, the
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structure of the cell envelope is important in determining bacterial susceptibility to the
CPEs and OPEs. There are significant structural differences between the outer envelopes
of Gram-negative and Gram-positive microorganisms. The outer envelope of Gramnegative bacteria is composed of an outer membrane and a cytoplasm membrane (or
inner membrane), which are separated by a thin intermittently cross-linked peptidoglycan
network. The outer leaflet of Gram-negative bacterial outer membrane contains high
levels of LPS (Scheme 3.1). On the other hand, Gram-positive bacteria only have one
lipid membrane (cytoplasm membrane) covered by a thick layer of heavily cross-linked
peptidoglycan (Scheme 3.1).5 In both cases, the peptidoglycan layer does not provide an
efficient barrier against diffusion of hydrophilic solutes (the peptidoglycan layer of
Gram-positive cell wall is accessible to molecules of molecular weight in the range of
30000 to 57000 Da). Moreover, proteins are another essential component for both Gramnegative and Gram-positive bacterial outer envelopes. Generally, Gram-negative bacteria
exhibit higher resistance to antimicrobial agents than Gram-positive microorganisms,
which is attributed to the more complicated outer envelope structure of the Gramnegative bacteria.6 Specifically, the presence of the efflux pumps on the outer membrane
of Gram-negative bacteria significantly impairs the penetration ability of antimicrobial
agents into the cell (Efflux pumps are proteinaceous transporters localized in the
cytoplasmic membrane of all kinds of cells. efflux is a mechanism responsible for
moving out of toxic substances and antibiotics outside the cell. From Wikipedia). One
important common characteristic of both Gram-negative and Gram-positive bacterial cell
envelopes is the net negative charge, which is provided by LPS for Gram-negative
bacteria, teichoic acids for Gram-positive bacteria and the anionic phospholipids from
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bacterial cytoplasm membrane and/or outer membrane, such as phosphatidylglycerol (PG)
and cardiolipin (CL) (Scheme 2.1).7 For Gram-negative bacteria, the negatively charged
outer membrane serves as the first point of contact for the cationic antimicrobial
compounds. Furthermore, the amphiphilic nature of the CPEs and OPEs may enhance
their ability to denature membrane proteins and perturb lipid membranes via hydrophobic
interactions. The biological functions of teichoic acids from Gram-positive bacteria are
not fully understood; some of their proposed functions include (ⅰ) binding of divalent
cations (particularly Mg2+), (ⅱ) regulation of autolytic enzymes, and（iii）barrier to
control the diffusion of nutrients and wastes.8-9 Although the cell wall of Gram-positive
bacteria is believed to be an open network and accessible to solutes with a broad range of
molecular weights,10 the cationic CPEs and OPEs may bind with the negatively charged
cell wall components, thus reducing their penetration through the cell envelope. As such,
dark toxicity of CPEs and OPEs against Gram-positive bacteria may stem from a
different mechanism than those towards Gram-negative bacteria. In summary, the
bacterial outer envelope should be one of the main sites of attack for the CPEs and OPEs,
due to the favorable electrostatic and hydrophobic interactions.
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Scheme 3.1. Structures of peptidoglycan and LPS on the bacterial cell wall.

In addition, since there are no advanced organelles in the bacteria, the cell wall and
membrane serve many essential biological functions, including structural support against
osmotic pressure gradients, nutrient and waste transport, metabolic reactions, and
synthesis.9 Therefore, compromises to the structural integrity of the bacterial cell
envelope may trigger a lethal effect. For example, ethylenediaminetetraacetic acid
(EDTA) has been demonstrated to cause the release of LPS molecules from E. coli outer
membrane by chelating Mg2+ or Ca2+ ions, which destabilizes the LPS assembly and
increases the permeability of the bacterial outer envelope.11
Some PPE-based cationic compounds with different structures, which exhibited
various toxicity against Escherichia coli (E. coli), were chosen for the initial study to
explore the structure-antimicrobial activity relationship (Scheme 1.3). Due to large
differences in molecular weight and spatial arrangement of the positively charged side
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and end groups, the interactions of these antimicrobial compounds with the bacterial
outer envelope were expected to be different, and it was anticipated that these differences
could result in different mechanisms of action against Gram-negative bacteria. In this
study, we examined the toxicity mechanisms of these antimicrobial materials. In
particular, direct visualization of damages to the bacterial outer envelope and changes to
bacterial morphology were found via scanning and transmission electron microscopy
(SEM and TEM) imaging of E. coli cells exposed to the selected materials. Laser
scanning confocal microscopy (LSCM) gives additional detailed information on the
antimicrobial mechanism of OPE-1.
1

O2 and the secondary ROS sensitized by the CPE and OPE materials have shown to

be to be highly toxic to bacteria by possibly inducing damages to proteins, RNA, DNA,
and unsaturated lipids.12-13 Due to the different structures and components of the bacterial
cell envelopes, Gram-positive and Gram-negative bacteria have been found to exhibit
different susceptibilities towards chemical damages induced by pure 1O2.14 Briefly, for
Gram-negative bacteria, 1O2 can react with the components of the outer membrane (e.g.,
LPS) and generate secondary ROS so that the damage to the bacteria is the culmination
of 1O2 damage of the cytoplasmic membrane and the lethal effect caused by the ROS
products on the outer membrane. However, for Gram-positive bacteria, 1O2 can rapidly
diffuse through the cell wall and cause lethal damages directly on the cytoplasmic
membrane. Aside from the intrinsic diffusing rate and reactivity of 1O2, the lightenhanced biocidal activity of CPEs and OPEs is also expected to be highly dependent on
the penetrating ability or the location of the compounds in bacteria.
Damages to the morphology of the Gram-negative E. coli and Gram-positive
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Staphylococcus epidermidis (S. epi) cells exposed to the biocidal compounds were
visualized by scanning and transmission electron microscopies (SEM and TEM).
5.2 Results and Disscussion
Previously, we have shown that the PPE-based cationic conjugated polymers (CPEs)
and oligomers (OPEs) with different side chains and repeat units exhibit a range of
toxicities against bacteria and different perturbation abilities against model membranes.1
Generally, the amphipathic properties, molecular size, aggregation state, and charge
density are factors modulating the interactions between CPEs and OPEs and their
biological targets. The motivation of the current study is to elucidate the mechanistic
origin of the different killing abilities among different CPEs and OPEs. SEM imaging
and the cytoplasmic membrane permeability assays are used to elucidate the interactions
between a CPE or an OPE with bacterial cell walls and membranes. The minimum
inhibitory concentration (MIC) and hemolytic concentration (HC) values serve as useful
parameters to evaluate the selectivity the compound, i.e., antimicrobial activity against
bacteria compared to cytotoxicity against mammalian cells.
5.2.1 CPEs and OPEs can disrupt bacterial cell walls and membranes
The addition of different CPE and OPE materials caused different visual changes to
ATCC 11303 E. coli cells. As shown in Figure 5.1, the addition of PPE-DABCO, PPETh and OPE-3 caused the E. coli cells to aggregate and precipitate (Figures 5.1D, G and
H). No visible changes occurred with the addition of OPE-1 or melittin (Figure 5.1B and
C). On the other hand, after the addition of two EO-OPE-1 compounds, the turbidity of
the E. coli cell suspension decreased (Figure 5.1E and F), implying that the EO-OPE-1s
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may have caused cell lysis. The same effects of the CPEs and OPEs on BL21(DE3)pLysS
E. coli cells were observed (data not shown).

Figure 5.1. Images of E. coli cells (ATCC 11303, ~108 CFU/ml) exposed to 10 µg/ml of
antimicrobials at 37℃ for one hour in the dark. A, E coli cells alone; B, Melittin; C,
OPE-1; D, OPE-3; E, EO-OPE-1(C3); F, EO-OPE-1(Th); G, PPE-DABCO; H, PPE-Th.
The bottom figure is a close up of E. coli suspensions in glass vials of A and E.
The effect of the different CPEs and OPEs on E. coli cell viability was determined by
counting the colony forming units of E. coli cells after exposure to 10 µg/ml for one hour
in the dark. Results are presented in Figures 5.2, 5.3 and 5.4. As shown, OPE-1 and
melittin did not exert significant toxicity. In contrast, all other CPEs and OPEs show
significant antimicrobial activities against the E. coli cells For example, the oligomer EOOPE-1(C3) induced close to 100% cell death in both E. coli strains (Figure 5.2B).
Previously, we have shown that the dark biocidal activity of the CPE and OPE is
associated with damages to bacterial cell walls and membranes by the direct contact
between these materials and bacteria. When the cell walls and membranes are perturbed,
cytoplasm contents, such as nucleic acids and proteins can leak out and these materials
can be detected by measuring the absorbance of the soluble fraction of the cell suspension
at 260 nm.15 Table 5.1 summarizes absorbance measurements of the supernatant of E.
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coli cells after incubating with the antimicrobial compounds. As shown, EO-OPE-1(C3)
causes the highest level of leakage from both E. coli strains, which correlates with its
bacteriolysis effect (Figure 5.1E) and high toxicity (Figure 5.2A and B). However, a
direct correlation between toxicities and level of soluble cell content caused by the CPEs
and OPEs cannot be drawn at this time primarily because the interaction between the
antimicrobial compounds and E. coli cell content (i.e., DNA and proteins) is not fully
understood. For example, polyvalent cations can readily precipitate DNA.16 Therefore,
low absorbance readings do not necessarily correlate with low levels of cell content
leakage. Nonetheless, some meaningful comparisons can be made from the absorbance
measurements. Figure 5.2, and results from our previous study, shows that OPE-3
exhibits much higher dark antimicrobial activity than OPE-1. OPE-3 is also known to
interact much more strongly with DNA compared to OPE-1.17 Therefore, DNA released
from the E. coli cells may form stable complexes with OPE-3 that can be pelleted during
centrifugation, resulting in a lower absorbance at 260 nm in the cell supernatant
compared to OPE-1 (Table 5.1).
Table 5.1. Absorbance at 260 nm for the antimicrobial compounds and their mixture with
soluble materials released from bacteria. The concentration of the antimicrobial materials
and E. coli cells are 10 µg/ml and 108 CFU/ml respectively. All samples were incubated
at 37℃ for 1 hour in 10 mM PBS, followed by centrifuging at 10000 rpm for 10 min. All
experiments were done in the dark.
Antimicrobial
Agents
Control
Melittin
OPE-1
OPE-3
EO-OPE-1(C3)
EO-OPE-1(Th)
PPE-DABCO
PPE-Th

Antimicrobial
compounds alone
0.06*
0.06
0.15
0.14
0.16
0.19
0.13
0.17

E. coli BL21(DE3)pLysS

E. coli (ATCC 11303)

0.20**
0.63
0.33
0.20
1.30
0.26
0.80
0.20

0.17**
0.46
0.31
0.19
0.88
0.31
0.79
0.22

* PBS buffer alone; ** E. coli cells alone in the PBS buffer
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Figure 5.2. Antimicrobial activities of CPEs and OPEs against E. coli cells. Exponential
growth phase E. coli cells (~108 CFU/ml) were incubated with 10 µg/ml CPEs or OPEs at
37℃ for one hour in the dark followed by 106 fold dilution. The diluted samples were
loaded on Luria broth plates. The reported survival percentage is the average of two
independent experiments and normalized to the control.
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Control

EO-OPE-1(C3)

Melittin

OPE-1

EO-OPE-1(Th)

PPE-DABCO

OPE-3

PPE-Th

Figure 5.3. CFU counting for the antimicrobial activities of CPEs and OPEs against E.
coli BL21(DE3)pLysS. Exponential growth phase E. coli cells (~108 CFU/ml) were
incubated with 10 µg/ml CPE or OPE at 37℃ for one hour in the dark followed by 106
fold dilution. The diluted samples were loaded on Luria broth agar plates.

Control

Melittin

OPE-1

EO-OPE-1(C3) EO-OPE-1(Th)
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Figure 5.4. CFU counting for the antimicrobial activities of CPEs/OPEs against E. coli
(ATCC 11303). Exponential growth phase E. coli cells (~108 CFU/ml) were incubated
with 10 µg/ml CPEs/OPEs at 37℃ for one hour in the dark followed by 106 fold dilution.
The diluted samples were loaded on Luria broth agar plates.
The ability of OPEs and melittin to depolarize the cytoplasmic membrane is
determined by using the cationic membrane potential-sensitive cyanine dye diSC3-5. The
distribution of diSC3-5 between cell membrane and periphery medium is dependent on
the cytoplasmic membrane potential gradient.18 This cationic dye readily partitions into
the bacterial cell membrane and aggregates within the membrane, causing selfquenching.19 If the antimicrobial compounds perturb the cell membrane, it can lead to the
loss of the membrane potential gradient, causing the dye to release into the medium. As a
result, the fluorescence intensity of the dye increases. Hancock et al. employed the
mutant E. coli DC2 cell with increased outer membrane permeability for their
cytoplasmic membrane permeability assay. Herein, the laboratory strain E. coli
BL21(DE3)pLysS cells growing with carbenicillin and chloramphenicol also possess
modified loose outer membranes.
After incubating E. coli cells in the exponential growth phase with diSC3-5 for one
hour, the fluorescence of this membrane potential dye decreased dramatically (Figure
5.5), which indicates that the dye has been taken up by the E. coli cells and that the cells
have unperturbed membrane potential gradients. As shown in Figure 5.6, these
antimicrobial compounds exhibit similar membrane permeability abilities against the two
different strains of E. coli cells. Melittin strongly interacts with bacterial cytoplasmic
membrane, causing dye release from the membrane and increasing the fluorescence of
the dye in the sample. Melittin exhibits increased membrane perturbation ability with
increased concentration. OPE-1 shows a similar concentration dependent trend, but
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fluorescence intensity is much lower than that caused by melittin, indicative of weaker
interaction between OPE-1 and bacterial. Surprising, the addition of EO-OPE-1(C3) to
both strains of bacteria caused increases in fluorescence at low oligomer concentrations,
followed by decreases of diSC3-5’s fluorescence at oligomer concentrations higher than
2 µg/ml. One explanation for the observed trend is that EO-OPE-1(C3) exerts its biocidal
activity by bacteriolysis. When the bacteria are disintegrated by EO-OPE-1(C3), the
bacterial cytoplasm is released and may strongly interact with the cationic membrane
potential dye and quench its fluorescence. Figure 5.7 show that DNA is effective at
quenching diSC3-5 fluorescence. Therefore the overall fluorescence intensity of diSC3-5
in Figure 5.6 is the result of two competing processes. Upon the perturbation of bacterial
cytoplasmic membrane by the antimicrobial agent, the released diSC3-5 initially
increases the sample’s fluorescent intensity. However, disruption of cell wall and
membrane can subsequently release DNA and other contents of the cytoplasm, which
effectively quench diSC3-5’s fluorescence, resulting in overall decreases in the
fluorescence intensity of diSC3-5. A similar trend was observed for OPE-3. Due to the
loose outer membrane of E. coli BL21(DE3)pLysS, the decrease of diSC3-5’s
fluorescence occurred at a lower concentration of OPE-3 than that of E. coli (ATCC
11303). As concluded by Hancock et al., since there is no correlation between the
membrane permeability of antimicrobial compounds and their lethal effect against
bacteria, other antimicrobial and inhibitory mechanisms may be involved.25 The high
membrane potential gradient perturbation ability of melittin only accounts for its efficient
interaction with bacterial cytoplasmic membrane. Even though the results of this assay
are not conclusive, it is clear that the four antimicrobial compounds (mellitin and three
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oligomers) used in this assay can interact with bacterial cytoplasmic membrane, although
the extent varies

Figure 5.5. Fluorescence change of diSC3-5 (0.4 µM) before and after mixing with fresh
exponential growth phase E. coli BL21(DE3)pLysS cells (107 CFU/ml) in the HEPES
buffer (5 mM HEPES, 5 mM glucose, pH 7.2). The same phenomenon was observed for
E. coli (ATCC 11303) cells.

Figure 5.6. Cytoplasmic membrane permeability of E. coli cells induced by melittin and
OPEs. The fluorescence changes of diSC3-5 as a function of antimicrobial compound
concentration are plotted.
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Figure 5.7. Effect of DNA (plasmid from E. coli BL21(DE3)pLysS) on diSC3-5’s (0.4
µM) fluorescence in the HEPES buffer (5 mM HEPES, 5 mM glucose, pH 7.2).
5.2.2 CPEs and OPEs selectively exert toxicity towards bacterial cells
We tested the inhibitory activities of CPEs and OPEs against E. coli cells in the dark.
As shown in Table 5.2, the antimicrobial compounds exhibit very similar inhibitory effect
on the two different strains of E. coli cells, implying that the physiological differences
between these E. coli strains have limited influence on their susceptibilities towards CPEs,
OPEs and melittin. Therefore, it is reasonable to conclude that the specific resistance
strategies

the

E.

coli

BL21(DE3)pLysS

acquired

against

carbenicillin

and

chloramphenicol antibiotics are not effective against our novel antimicrobial agents. In
particular, OPE-3 and PPE-Th exhibit excellent inhibitory activities against E. coli cells
(Table 5.2). At relatively low concentrations, the two EO-OPE-1 compounds, PPEDABCO, and melittin show efficient inhibitory activity against the E. coli cells. However,
no inhibitory activity is observed for OPE-1 within the tested concentration range.
In order to evaluate the biocidal selectivities of the CPEs and OPEs, we tested their
hemolytic activity against human RBCs. The concentrations necessary to cause 50%
RBC hemolysis (HC50) of OPE-1 and OPE-3 are fairly high (Table 5.2). Thus, no
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significant hemolytic activity is observed for OPE-1 and OPE-3 within the tested
concentration range. Under the same conditions, the two EO-OPE-1 compounds
exhibited moderate hemolytic ability against RBC with HC50 values around 20 µg/ml.
However, significant blood cell lysis was observed for polymer PPE-DABCO and
peptide melittin at relatively low concentrations with HC50 values of around 5 µg/ml. We
were unable to determine the HC50 value for PPE-Th using this method, probably due to
the strong interaction of PPE-Th with hemoglobin that precipitated rather than lysed
RBCs. A different method to measure hemolysis, based on Coulter Counter (Beckman
Coulter, Miami, FL) measurements, was used to determine HC50 of PPE-Th and the value
is about 1 µg/ml (data not shown).
Overall, the oligomer OPE-3 exhibited the highest selectivity towards bacterial cells
while the polymeric PPE-DABCO and PPE-Th and antimicrobial peptide melittin
showed poor biocidial selectivity. The latter three compounds show efficient biocidal as
well as hemolytic activities.
Table 5.2. Minimum inhibitory concentrations and hemolytic concentrations of the
antimicrobial compounds in the dark.
Antimicrobial Agents
OPE-1

MIC90 (µg/ml)
BL21(DE3)pLysS
ATCC 11303
>30
>30

HC50 (µg/ml)
>100

OPE-3
EO-OPE-1(C3)

0.5
2

0.5
2

>50
24

EO-OPE-1(Th)
PPE-DABCO
PPE-Th

2
2
0.3

1
2
0.5

16
4
N/D*

Melittin (70% purity)

6

4

5

*unable to make measurement
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5.2.3 CPEs and OPEs can induce changes to bacterial cell morphology
5.2.3.1 Effect of the CPEs and OPEs on Gram-negative bacteria
In order to further elucidate the CPEs and OPEs’ effects on bacterial cells, the
morphological changes of E. coli cells with the addition of the different antimicrobial
agents were examined by SEM imaging. As shown in Figures 5.8A and 5.9A, the two
strains of E. coli cells alone in PBS buffer maintain their integrity with a smooth cell
surfaces. E. coli cells treated with melittin are still able to maintain the intact cell
structures, but some cells now appear more rough and wrinkled (Figures 5.8B and 5.9B,
see arrows). E. coli cells treated with the polymers PPE-DABCO and PPE-Th exhibit
obvious morphological changes compared to the untreated samples (Figure 5.8C, 5.8D,
5.9C, and 5.9D). The surfaces of polymer treated cells appear more rough, with possible
formation of circular blebs (Figure 5.9C, see arrows), and the cells appear to be
agglomerated.
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Figure 5.8. SEM images of E. coli (ATCC 11303) cells (108 CFU/ml) incubated with 10
µg/ml antimicrobial compounds for one hour in the dark. The scale bars of these images
are 4 µm.
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Figure 5.9. SEM images of E. coli BL21(DE3)pLysS cells (108 CFU/ml) incubated with
10 µg/ml antimicrobial compounds for one hour in the dark. The scale bars of these
images are 3 µm.
The addition of oligomeric EO-OPE-1(Th) and EO-OPE-1(C3) also caused changes to
cell morphology. Most BL21(DE3)pLysS cells exposed to EO-OPE-1(C3) became
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completely disrupted, appearing as amorphous material rather than cells (Figure 5.9E).
ATCC cells exposed to EO-OPE-1(Th) showed roughening of the cell surface (Figure
5.8D) while BL21(DE3)pLysS cells, mostly maintained their integrity with a smooth cell
surface (Figure 5.9F).
It is important to note that the molecular size of the antimicrobial compounds is one of
the determining factors in their interactions with bacteria. The relatively large sizes of the
polymeric CPEs hinder their ability to penetrate into the cell wall and membrane, and as a
result, they may only cause damages to the cell surfaces and cause cell aggregation. On
the other hand, the smaller and unique linear structures of the oligomeric EO-OPE-1(C3)
and EO-OPE-1(Th) compounds enable them to easily penetrate cell walls and membranes
without at first causing serious morphological changes to the cell surface. These
oligomers may then exert their cytotoxicity by inducing small membrane defects and
inhibiting metabolic pathways. This proposed toxicity mechanism of the linear oligomers
is supported by our observation that the addition of the two compounds significantly
decreases the optical density of E. coli cell suspensions (Figures 5.1E and F).
Disintegration of bacterial cells is likely caused by the insertion of the linear oligomers
into the cell walls and membranes and subsequent disruption of these structures. The
more linear of the two oligomers, EO-OPE-1(C3), showed highest cell lysis activity,
resulting in a large amount of cell debris that was both detected by absorbance
measurements (Table 5.1) and visualized by SEM (Figure 5.9E). Due to the strong lytic
activity of EO-OPE-1(C3) against ATCC 11303, no sample was visualized with SEM
imaging. In addition, it is worth mentioning that because of the resolution limit of the
SEM instrument, neither individual antimicrobial molecules nor their aggregates could be
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clearly visualized.
Many naturally occurring and synthetic antimicrobial agents with cationic and
amphiphilic properties exert their toxicity by disrupting the integrity of bacterial cells.
Moreover, small hydrophilic molecules are able to readily penetrate the bacterial outer
membrane and/or peptidoglycan layer. As described above, CPEs and OPEs with
different molecular weights may penetrate the bacterial outer envelope to various extents,
leading to different toxic mechanisms of action.

Figure 5.10. SEM (A1, A2 and A3) and TEM (B1-D3) micrographs of E. coli (ATCC
11303) cells (108 CFU/ml) alone (A1, B1 and C1), incubated with 10 µg/ml PPE-Th (A2,
B2, C2 and D2) and EO-OPE-1(C3) (A3, B3, C3 and D3) for one hour in the dark.
TEM was also used to image the structural changes on E. coli cells upon incubation
with the antimicrobial agents. As shown in Figure 5.10 (A1, B1 and C1), the E. coli cells
alone maintain their integrity with a smooth cell surface, and the intact bacterial outer
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envelopes are clearly seen. After 1 hour incubation in the dark, the E. coli cells (108
CFU/ml) exposed to PPE-Th or EO-OPE-1(C3) (10 µg/ml) show striking, but different
structural damages. The surfaces of PPE-Th treated cells appear to be rougher (Figure
5.10 A2), and the cell outer membrane is significantly remodeled by the polymer,
possibly leading to the formation of blebs on the bacteria surface (see arrows in Figure
5.10 B2 and C2). In addition, an obvious, but small population of the PPE-Th treated
cells is empty (see arrow in Figure 5.10 D2), which implies that these cells have released
their content as a result of compromised cell integrity. A remarkable characteristic feature
of the EO-OPE-1(C3) treated cells is the appearance of abundant amorphous material,
presumably cell content (Figure 5.10 A3). TEM images confirm the collapse of bacterial
structure induced by EO-OPE-1(C3) as a large number of empty or partially empty cells
with debris are observed (Figures 5.10 B3 and C3). Moreover, TEM imaging also
captured the site and process of the release of internal cell content from some bacteria
(see arrow in Figure 5.10 D3).
OPE-1 and EO-OPE-1(C3) share the same molecular backbone and are of similar size,
but have different spatial arrangements of the cationic functional groups (Scheme 1.3),
which may result in different antimicrobial activities and mechanisms of action.
Generally, OPE-1’s dark biocidal activity is not as high compared with other CPEs or
OPEs.19-20 Herein, the lethal effect of OPE-1 on two Gram-negative bacteria is examined
by LSCM imaging, which is capable of tracking real-time changes to the structure of
bacteria. As shown in Figures 5.11 A1 and A2, most of the untreated bacteria were live.
However, a significant number of bacteria were killed and agglomerated by the addition
of OPE-1 under the specific experimental condition (Figures 5.11 B1 and B2).
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Interestingly, the release of fibrous and threadlike materials, probably cell content, from
dead bacteria is clearly observed (Figures 5.11 D1 and D2, see arrows). As described
earlier, OPE-1 can induce membrane depolarization in E. coli, which implies the cell
transmembrane electrochemical gradient is perturbed by OPE-1. As a result, the
microorganisms may not be able to generate energy, and the water and ion flow across
the membrane may become disregulated, leading to possible cell swelling and/or lysis.
Moreover, for both E. coli and PAO1, some of the dead bacteria (Figures 5.11 D1 and D2)
seem to be larger than the corresponding live bacteria (Figures 5.11 C1 and C2), which
may result from a single swelling dead bacterium and/or the aggregation of dead bacteria.
TEM imaging also confirms the loss of cell content from E. coli induced by OPE-1
(Figure 5.12).
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Figure 5.11. LSCM imaging of E. coli (ATCC 29425) and PAO1 cells (~108/ml) alone
(A1 and A2) and treated with 42.5 µg/ml OPE-1 (B1 and B2) in the dark. The merged
images are further split into red channel (C1 and C2, live bacteria) and green channel (D1
and D2, dead bacteria).
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Figure 5.12. TEM micrographs of E. coli cells alone (A) and incubated with 10 µg/ml
OPE-1 (B, C and D) for one hour in the dark.
So far, we have shown that the cytoplasmic membrane in Gram-negative bacteria is
one of the main targets for oligomeric OPEs. Although the penetration ability of the
polymeric CPEs through the outer membrane and peptidoglycan layer in E. coli cell is
largely hindered by their bulky sizes, these compounds may still interact with the
bacterial cytoplasmic membrane. Herein, further characterizations on the biocidal
mechanisms have been performed with representative CPEs and OPEs against model E.
coli cells. Although interactions with the plasma membrane are necessary in the
bactericidal actions of CPE and OPE compounds, interactions of these compounds with
the bacterial cell envelope are also crucial since the cell envelope serves as the first pointof-contact for exogenous materials.
As described earlier, the cell envelopes of Gram-positive and Gram-negative bacteria
are compositionally and structurally different. Understanding the interactions of the CPE
and OPE compounds with the different cell surfaces will not only provide a deeper and
more complete understanding of the toxicity mechanism, but will also give us insights to
the susceptibilities of the two different classes of bacteria. The complexities of the cell
envelopes make such biological entities difficult to mimic with model systems.
As shown in Figure 5.13, the untreated E. coli cells (1×108 CFU/mL) in PBS appear
structurally intact and the outer envelopes are clearly visible (Figure 5.13 A1, A2, and
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A3). After 1 hour incubation with OPE-3 or EO-OPE-1(C3) in the dark, the E. coli cells
show remarkable structural damages (Figure 5.13 B and C). The attachment of OPE-3 to
the bacterial cells extensively remodeled the outer membrane, leading to the roughening
of the cell surface and formation of blebs (Figure 5.13 B). In addition, the cytoplasm
density of the majority of OPE-3 treated cells decreased, which implies that the
cytoplasm contents were being released during incubation through damaged cell
envelopes. Disruption and permeabilization of the cell envelope can also lead to the
penetration of OPE-3 into the bacteria cytoplasm. The cationic and amphiphilic oligomer
can then bind to and disrupt other cellular components, for example, proteins and nucleic
acids. Likewise, incubation with the oligomeric EO-OPE-1(C3) also led to significant
disruptions to the cell envelope (Figure 5.13 C), which is consistent with previous
findings that EO-OPE-1(C3) can permeabilize cell envelopes and cause cell lysis
Furthermore, the TEM images in of cells incubated with EO-OPE-1(C3) (Figure 5.13 C)
also showed time-dependent release of the cell cytoplasm, where only a small population
of the cells show partial cytoplasm leakage/damage after exposure to the oligomer for 10
min (Figure 5.13 C1), whereas most cells were empty and/or collapsed after one hour
(Figure 5.13 C3). This finding is consistent with a previous observation that EO-OPE1(C3) exerts time-dependent biocidal activity against E. coli cells in the dark.20
The outer membrane of Gram-negative bacteria, such as E. coli, is permeable to solutes
with a molecular weight smaller than 600 Da due to the presence of porin channels.21 In
terms of molecular weight and chain length, PPE-Th and EO-OPE-1(C3) represent two
extremes in our current antimicrobial agent library (Scheme 1.3), whereas OPE-3 falls in
between. PPE-Th, with a high molecular weight, is believed to exert toxicity towards
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Gram-negative bacteria by disrupting the outer membrane (LPS assembly) through an
“ion-exchange” process.2, 11 However, PPE-Th is not expected to penetrate through the
bacterial envelop and get into the cytoplasm due to its high molecular weight. In contrast,
EO-OPE-1(C3) with its needlelike structure may easily penetrate through the outer
membrane and the thin peptidoglycan layer in the bacteria without causing serious
structural damages. Subsequently, it can reach, perturb and even penetrate the bacterial
cytoplasmic membrane, leading to cell lysis. The molecular weight of the intermediate
sized OPE-3 exceeds the permeability limit of the porin channel. Thus, similar to PPE-Th,
the oligomer may exert toxicity against E. coli by disrupting the outer membrane.
However, due to its rod-like structure and moderate molecular weight, OPE-3 may
penetrate through the peptidoglycan layer, disturb the cytoplasmic membrane and trigger
the release of cell content. Therefore, both molecular weight and architecture of the CPEs
and OPEs are key factors controlling their interactions and toxicities with E. coli cells.
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Figure 5.13. TEM micrographs of Gram-negative E. coli (ATCC 11303) cells (108
CFU/mL) alone (A1, A2 and A3), incubated with 10 µg/mL OPE-3 (B1, B2, B3 and B4)
and EO-OPE-1(C3) (C1, C2 and C3) for different time intervals in the dark.
Generally, the antimicrobial activities of CPE and OPE materials are greatly enhanced
with the irradiation of UV or visible light such that they exhibit rapid and efficient
toxicities at very low doses. The light-enhanced toxicities of the compounds are in part
contributed by the dark biocidal mechanisms of the CPE and OPE compounds, such as
those visualized in Figure 5.13. Light enhanced biocidal actions of CPEs and OPEs,
however, have not been directly visualized. In this study, Gram-negative E. coli cells
incubated with oligomeric OPE-3 and EO-OPE-1(C3) and polymeric PPE-DABCO under
UV-irradiation have been imaged with TEM and SEM.
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Similar to untreated cells (Figure 5.13A), a control sample of E. coli cells irradiated for
30 min without the addition of biocidal compounds appeared intact with unperturbed
cytoplasm (Figure 5.14A). Thus UV-irradiation alone did not cause obvious damages to
cell morphology, consistent with our previous findings that UV-irradiation alone causes
very low-level toxicity to E. coli cells. However, the addition of OPE-3 or EO-OPE-1(C3)
with UV-irradiation caused catastrophic damages to the bacteria (Figure 5.14 B and C).
In addition to the disruptions to the cell surfaces similar to those seen in cells incubated
with the oligomers in the dark (Figure 5.13 B and C), the cytoplasm of the UV-irradiated
cells is also clearly damaged. In the OPE-3 and UV-light treated sample, a large amount
of amorphous materials outside the cells was observed, which may be complexes of OPE3 with cell envelope components such as LPS and/or released cell content. In contrast to
the cells incubated with EO-OPE-1(C3) in the dark (Figure 5.13 C1) where the cytoplasm
remained relatively intact after 10 minutes, UV-irradiation in the presence of EO-OPE1(C3) for the same duration of time caused significant damages to the cell, including
decreased density of the cytoplasm. However, the time dependent bacteriolytic effect as
observed by the loss of cell cytoplasm, was not observed under UV irradiation (Figure
5.14 C). This may be partly explained by the appearance of the dark, therefore dense,
features in the UV-irradiated cells. Although the nature of these dark inclusions is not
known, they could be oxidatively damaged and cross-linked cytoplasm components, such
as proteins and nucleic acids. It is important to note that there was less leakage of the
bacterial cytoplasm caused by the oligomers under UV-irradiation compared to their dark
actions, which implies that the bacteria can be killed by the oligomers without releasing
toxic debris.
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Figure 5.14. TEM micrographs of Gram negative E. coli (ATCC 11303) cells (108
CFU/mL) alone (A1, A2 and A3), incubated with 10 µg/mL OPE-3 (B1, B2 and B3) and
EO-OPE-1(C3) (C1, C2 and C3) for different time intervals under UVA irradiation.
Polymeric CPEs have been observed to strongly bind to and remodel the outer
membrane (previous findings of TEM imaging) of E. coli cells in the dark. Although their
high molecular weights attenuate their ability to penetrate through the cell envelope, the
oxygen radicals generated by the CPE compounds under UV-irradiation may cause
sufficient damages and defects on the cell envelope to allow these polymeric agents to
reach the cell interior and/or cell cytoplasm to be released. Similar to OPE-3, under UVlight irradiation, PPE-DABCO caused catastrophic damages to the bacteria cell envelope
as well as induced the leakage of cell cytoplasm as evidenced by the empty (lighter
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colored) cells and the appearance of amorphous materials outside the cells (Figure 5.15 B
and C). These morphological changes are induced by the biocidal polymer as cells
irradiated by UV-light alone are intact and smooth (Figure 5.15 A). Damages induced to
the cell envelope by PPE-DABCO under UV-irradiation are further confirmed by the
drastic roughening of the cell surface imaged by SEM. Additionally, SEM imaging also
confirmed the presence of amorphous materials outside the cells, which could be leaked
cytoplasm and material complexed with the polymer (Figure 5.15 D and E).

Figure 5.15. TEM (A, B and C) micrographs of Gram-negative E. coli (ATCC 11303)
cells (108 CFU/mL) alone (A), incubated with 10 µg/mL PPE-DABCO (B and C) under
UV-420 irradiation for 30 min. SEM (D and E) micrographs of E. coli cells alone (D) and
incubated with 1 µg/mL PPE-DABCO (E) under UV-420 irradiation for 60 min.
It is evident from our results that UV-irradiation causes further damages to the E. coli
cell morphology in the presence of oligomeric and polymeric compounds. 1O2 has a
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relatively long lifetime (10-6-10-5s) and diffusion distance in pure water. However, in
cells, both lifetime and diffusion range of 1O2 must be significantly reduced due to its
high reactivity towards biomolecules in the cytoplasm.12,

22

As a result, the damage

caused by 1O2 may be related to the positions of the sensitizers in the cells, whether at the
cell surface or in the cell interior. Likewise, locations of damage of the bacteria under
UV-irradiation also confirm the presence of the CPEs or OPEs, either at the cell surface
or inside the cells. This “self-promoted uptake” mechanism,23 which has been extensively
studied for antimicrobial peptides, may also apply for the CPE and OPE compounds
where defects created by the CPEs and OPEs on the bacterial outer membrane facilitate
their entrance into the cell interior.
Results from these studies reveal some mechanistic insights to the different biocidal
efficiencies and selectivities of the CPE and OPE materials. The following are three
important modulating factors for the observed biocidal and hemolytic activities of the
tested compounds. First, the molecular size, shape, and aggregation state determine
whether the compounds can penetrate the bacterial outer membrane and reach the
cytoplasmic membrane. This factor explains the toxicities and cell lytic activity of the
CPEs and OPEs. In general, the oligomeric OPEs and oligo-peptide melitin appear to be
small enough to penetrate the bacterial outer membrane once they bind to cell surfaces
due to attractive electrostatic interactions. However, the penetrating ability of the
polymers is compromised due to their large sizes.24 Second, a compound’s ability to
perturb bacterial and mammalian cytoplasmic membranes determines its biocidal
selectivity. Because OPE-3’s perturbation ability against model bacterial membrane is
rather effective compared to model mammalian membrane (made of cholesterol and 1,2-
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dioleoyl-sn-glycero-3-phosphocholine),25 OPE-3 possesses high biocidal selectivity. In
contrast to OPE-3, PPE-DABCO perturbs both model bacterial and mammalian
membranes, leading to a poor biocidal selectivity. Even though the two EO-OPE-1
compounds and OPE-3 can cause similar levels of damage to model bacterial membrane,
the high perturbation ability against model mammalian membranes endows the two EOOPE-1 compounds relative high hemolytic activities. Third, the ability of a compound to
interact and denature membrane proteins provides another pathway for toxicity. The
ability of CPEs to complex and denature the native protein conformation of BSA gives us
an explanation for its high antimicrobial activity when the compound does not exhibit
significant lytic or membrane perturbation abilities. For example, the high inhibitory
ability of PPE-Th against E. coli cells is believed to derive from its high lipophilicity
property to efficiently damage bacterial cell wall and membrane, including membrane
proteins. In addition, since the exponential growth phase E. coli cells, which are
undergoing fast propagation, was employed in the antimicrobial investigations, other
antimicrobial and inhibitory mechanisms may be involved, such as interference with
bacterial metabolic pathways.
It has been previously observed that the addition of polymeric PPE-Th can cause E.
coli cells to aggregate and precipitate. In contrast, EO-OPE-1(C3) was found to decrease
the optical density of a E. coli cell suspension and induce the release of 260 nm absorbing
materials (e.g. DNA and protein), which may be caused by the lysis of the cells. The
polymeric PPE-Th is large, fairly hydrophobic and tends to form large aggregates in
aqueous solution.26 However, EO-OPE-1(C3) with the functional cationic groups on the
molecular termini is a small needle-like molecule. Jérôme et al. proposed that
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antimicrobial polycationic compounds with relatively high molecular weights may exert
toxicity against Gram-negative bacteria via binding strongly to LPS and leading to the
disruption of the cell outer membrane.2 Because of the attractive electrostatic and/or
hydrophobic interactions, PPE-Th may bind strongly to the bacterial outer membrane, but
its penetrating ability through the outer membrane and peptidoglycan layer may be
limited by its large molecular size. As a result, the polymeric PPE-Th binds to bacterial
surface and causes damage predominately to the surface of bacteria, including inducing
cell agglomeration; after that, PPE-Th may also further damage the bacterial cytoplasm
membrane and induce cell content release. On the other hand, the small and needle-like
features of EO-OPE-1(C3) may provide the oligomer the ability to permeate through the
outer membrane and peptidoglycan layer and allow it to disrupt the cytoplasm membrane,
leading to the lysis of the bacteria. Taken together, a general bactericidal action scheme
for the polymeric CPEs and oligoermic OPEs is proposed in Figure 5.16, and it is
reasonable to apply this model to other antimicrobial agents with similar structures.
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Figure 5.16. Proposed antimicrobial mechanism for CPEs and OPEs in the dark.
5.2.3.2 Effect of the CPEs and OPEs on Gram-positive bacteria
The CPE and OPE materials have been shown to exert toxicity towards both Gramnegative (e.g., E coli.) and Gram-positive bacteria, which have compositionally and
structurally different cell envelopes as described above. Bactericidal actions of the
compounds on Gram-positive bacteria have not been directly visualized previously. In
this study, the dark and light-enhanced antimicrobial actions of oligomers and polymers
on the Gram-positive S. epi bacteria were visualized for the first time via TEM and SEM
imaging. S. epi cells incubated with oligomeric EO-OPE-1(C3) in the dark for 10-60
minutes do not appear damaged, with intact cell envelope and cytoplasm, compared with
the control sample (Figure 5.17A). UV-irradiation alone also did not cause any obvious
damages to the cells (Figure 5.17B1). However, UV-irradiation in the presence of CPE
and OPE compounds caused obvious damage to the cell surfaces with PPE-DABCO
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inducing the highest level of roughness to the cell surface (Figure 5.17B2, B3, and B4).
In contrast to extensive damage induced in Gram-negative E. coli cells, however, damage
induced by the biocidal compounds in the Gram-positive S. epi cells under UV irradiation
seems to be localized only to the cell surface. The compounds do not appear to have
caused sufficient defects that extend through the cell envelope to cause leakage of the
cytoplasm, for example. SEM imaging further verifies the cell surface damage caused by
PPE-DABCO in similar conditions (Figure 5.18).
It has been determined that the CPEs and OPEs exhibit both dark and light-enhanced
antimicrobial activities against Gram-positive bacteria at concentrations lower than that
used for the electron microscopy experiments in this study. In addition, at similar
concentrations of the CPE and OPE compounds, UV irradiation always increases the
toxicities of the compounds. As shown in Figure 5.17B, the cytoplasm of the S. epi cells
do not appear damaged, even under UV-irradiation with the biocidal compounds, which
implies that the tested compounds were not capable of penetrating through the Grampositive cell envelop. Boix and co-workers have found that the eosinophil cationic
protein can induce significant morphological damages to the Gram-negative E. coli cells,
but the protein does not induce any damage to the morphology of Gram-positive
Staphylococcus aureus (S. aureus) cells under the same conditions.27 One explanation of
this phenomenon is that the eosinophil protein can penetrate the E. coli cell envelope via
the “self-promoted uptake” mechanism and then release the cell content. However, the
thick and tough peptidoglycan layer in the Gram-positive bacterial cell walls provides a
sufficient barrier to prevent damage to the cytoplasm. Meanwhile, the eosinophil protein
exhibits high affinity toward bacterial peptidoglycan. The same principle may also
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account for the similar observations of the effect of the CPEs and OPEs on Gram-positive
S. epi cells. The thick and negatively charged Gram-positive bacteria cell wall serves as
the main binding site for the cationic CPE and OPE compounds but can also prevent the
penetration of the compounds into the cell interior which may cause further damages to
the cell. However, since the CPE and OPE compounds are toxic toward Gram-positive
bacteria, disruption of the structure, and thereby function, of the peptidoglycan layer and
anionic teichoic/lipoteichoic acid, seems to be sufficient for inducing cell death and
serves as the toxicity mechanism for these compounds against Gram-positive bacteria.

Figure 5.17. TEM micrographs of S.epi (ATCC 14990) cells (4×108 CFU/mL) alone
incubated with 25 µg/mL antimicrobial agents in the dark or under UV-light irradiation
for various periods.
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Figure 5.18. SEM micrographs of S.epi (ATCC 14990) cells (108 CFU/ml) alone (A),
incubated with 10 µg/ml PPE-DABCO (B) under UV-420 irradiation for 60 min.
5.2.4 Summary
It is clear from our results that the polymeric CPE and oligomeric OPE materials exert
toxicity towards Gram-negative and Gram-positive bacteria through different
mechanisms. While the materials cause visible damage toward only the cell walls of
Gram-positive bacteria, they damage the cell wall, plasma membrane, proteins, and
plasmid DNA in Gram-negative bacteria. Our results indicate that the structures of the
antimicrobial agents and bacterial outer envelope control their interactions as well as the
biocidal mechanisms. In terms of bacteria cell envelope structures, the relatively thin and
soft cell envelope in Gram-negative E. coli cells does not serve as an efficient barrier for
the oligomeric OPEs in the dark, but can impair the penetrating ability of bulky
polymeric CPEs. Under UV-irradiation, all of the tested antimicrobial compounds can
cross the cell envelope of the Gram-negative E. coli cells and cause damage to the
cytoplasm, including oxidative and covalent modifications of proteins and plasmid DNA.
In contrast, the thicker and tougher cell envelope in Gram-positive bacteria seems to be
an efficient permeability barrier for the CPEs and OPEs both in the dark and under UVirradiation. The cell envelope is also the main target of the CPEs and OPEs.
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Damages to E. coli cells in the dark reveal the important role molecular structure of
the CPE and OPE compounds play toward their toxicity mechanism. The large polymeric
CPEs with high charge density may sequester and remove molecules from the bacterial
surface and destabilize the cell envelope and outer membrane through an “ion-exchange”
process, while the small oligomeric EO-OPE-1(C3) may easily cross the outer membrane
without causing serious damages and directly disturb the cytoplasmic membrane and
cytoplasm. The intermediate sized OPE-n compounds can induce damages to both
bacterial surface and cytoplasm. In summary, the membrane activity of the CPEs and
OPEs are affected by many factors, such as molecular conformation, size, side functional
groups, and membrane composition.
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Chapter 6 Antifungal Activities of the CPEs and OPEs
6.1 Introduction
Fungal infection is one of the most pressing public healthcare concerns worldwide.1
The

increased

emergence

of

fungal

infections

especially

associated

with

immunocompromised patients and medical devices and the shortage of efficient
treatments has prompted the discovery and development of new antifungal agents.2 The
CPEs and OPEs with controlled chain lengths and functional groups have been
demonstrated to exhibit significant light-activated biocidal activities against a broad
range of clinically relevant pathogens, including Gram-positive and Gram-negative
bacteria, viruses and biofilms.3-5
Because of the general mechanism(s) by which CPEs and OPEs inactivate bacteria and
viruses, we investigated in this study the utility of the compounds as antifungal agents.
The antifungal activities of a set of antimicrobial CPEs and OPEs against the vegetative
eukaryotic Saccharomyces cerevisiae (S. cerevisiae) cells and ascospores/asci were
measured. S. cerevisiae is a common opportunistic human pathogen and has long been
used as a model fungal organism.6 Because the cell envelope serves as the first point-ofcontact for biocidal agents, the structure of the S. cerevisiae cell envelope has been the
focus of many antibiotic development studies.2 Ultrastructural and biochemical analyses
reveal that the S. cerevisiae cell wall has a thick (100-200 nm) and layered structure and
is largely composed of polysaccharides and proteins, with chitin being a minor
component (Scheme 6.1).7-9 The outer layer of the cell wall is comprised primarily of
glycosylated mannoproteins and serves as an impermeable barrier to macromolecules due
to the presence of the branched carbohydrate side chains of the mannoproteins. In
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addition, these carbohydrate side chains contain many phosphodiester bridges, which
give rise to a negatively charged cell surface at physiological pH.8 The inner layer of the
cell wall is permeable and comprised of glucans and chitin; this fibrillar layer provides
mechanical strength to the cell wall. Beneath the cell wall is the cytoplasmic membrane,
which is about 7.5 nm thick and contains polar lipids and proteins.10 The lipids are
distributed asymmetrically in the membrane, where the inner leaflet is largely composed
of anionic phosphatidylserine (PS) and phosphatidylinositol (PI), zwitterionic
phosphatidylethanolamine (PE), while the outer leaflet is enriched in zwitterionic
phosphatidylcholine (PC) and sphingolipids of varying charges.10
Some yeast cells produce ascospores when they encounter certain environmental
stresses, such as a lack of nutrients.11 The spores are in a dormant state, which enables
them to survive for long periods in unfavorable environments.12 Ascospores are resistant
to ambient stresses, such as antibiotics, alcohols, and moderate heat. Extreme conditions,
such as strong oxidants, high heat, and γ-radiation, can efficiently inactivate bacterial and
fungal spores. However, these treatments are neither environmentally friendly nor
practical to use in the treatment of patients. Once spores are exposed to suitable
conditions, they can germinate and become pathogenic. Unlike bacterial endospores,
yeast ascospores form through a meiotic process.11 Ascospores have an unique
multilayered wall, which enables them to be more resistant to environmental stresses and
damages compared to vegetative cells (Scheme 6.1).11 The two inner layers of the
ascospore wall are composed of polysaccharides mannan and glucan.11 On top of the
glucan layer is a layer of chitosan and a layer of cross-linked dityrosine.13-14 Multiple
ascospores are enclosed by the ascal coat, which is derived from the cytoplasmic
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membrane and cell wall of the vegetative mother cell,11 to form an ascus. These thick
protective structures make the inert ascospores highly resistant to the antibiotics. A 2%
glucose solution has been shown to be an excellent germinating agent for the yeast
ascospores.15 And, applying antimicrobial agents under conditions that induce
germination has been proven to be an efficient strategy to inactivate bacterial spores.16
Scheme 6.1. Models of yeast vegetative cell wall and spore wall organization

Because of the cationic nature of the PPE-based polymers and oligomers, the materials
are expected to readily associate with anionic groups on the surfaces of vegetative yeast
cells and asci. After exposure to UV/visible light, singlet oxygen and secondary ROS
species generated by the bound CPEs and OPEs could cause severe damages to the outer
envelopes of these cells.
In the current study, we investigated the antifungal activities of a series of CPEs and
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OPEs (Scheme 1.3) in the dark and under UV-irradiation against S. cerevisiae vegetative
cells, germinated ascospores and asci. The exact molecular weights of PPE-DABCO and
PPE-Th are currently unavailable, but the number average molar mass (Mn) values are
estimated to be within the range of 20-30 kD. As a comparison, the Food and Drug
Administration (FDA)-approved, broad-spectrum antifungal agent Amphotericin B
(AmB), was used as a benchmark antibacterial agent. It has been proposed that AmB
exerts its toxicity by penetrating the fungal cell wall and binding to ergosterols, thereby
perturbing the function of the fungal cytoplasmic membrane.2 In this study, the viability
of cells exposed to CPEs and OPEs under different conditions were determined.
Additionally, cellular damages induced by the CPEs and OPEs on the morphological
level were visualized by scanning electron microscopy (SEM).
6.2 Results and Discussion
The vast majority of antibiotics that have been developed to control bacterial infections
are not effective against fungi or spores.17 In addition, growing attention is being paid to
the need to decontaminate environments contaminated by spores. Here, we report the
antifungal and sporicidal activities of a class of synthetic arylene-ethynylene-based
polymers and oligomers.
6.2.1 CPEs and OPEs exhibit efficient dark and light-enhanced antifungal activities
Figure 6.1 summarizes the biocidal effects of different CPEs and OPEs in the dark
(blue bars) or with UV/visible light irradiation (red bars) against fresh S. cerevisiae
vegetative cells (ATCC 9763) prepared in the YPD medium for 4 hours. As shown, in the
absence of irradiation, the polymeric PPE-DABCO exhibited significant antifungal
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activity against the vegetative cells in 60 min, reducing the number of CFU by more than
2 orders of magnitude. By comparison, the oligomeric EO-OPE-1(DABCO), OPE-3 and
EO-OPE-1(C3) induced approximately a 10-fold decrease in CFU in the dark, on the
same order as AmB. However, limited dark inactivation activities were observed for EOOPE-1(Th, C2) and PPE-Th. UV irradiation significantly enhanced the inactivation
activities of all CPEs and OPEs against the yeast vegetative cells relative to the activities
obtained in the dark. After just 30 min of irradiation, no living cells were detected.
Interestingly, AmB’s biocidal activity decreased with UV-irradiation compared to its
activity in the dark and is comparable to the inactivation caused by the UV-light alone
(Figure 6.1). This is likely due to: 1) damages caused by the UV-light to the polyene
rings of the AmB molecules, thus compromising its antifungal activity and/or 2) the
shorter incubation time (30 min) employed with the UV-light irradiation experiment as
compared to the dark incubation experiment (60 min).
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Figure 6.1. Inactivation of the S. cerevisiae vegetative cells (ATCC 9763) (~2×106
CFU/ml) at exponential phase by CPEs or OPEs (10 µg/ml) in the dark (blue bars, 60 min
incubation) or with UV-light irradiation (red bars, 4 UV-lamps and 30 min incubation).
The detection limit for the assay is 6 to7 logs of CFU/ml. UVA and LZC-420 irradiation
alone causes about 0.16 and 0.17 log of inactivation, respectively.
It has been shown previously that CPEs and OPEs can bind to and denature anionic
protein assemblies in the dark18 and covalently modify cytoplasmic proteins under
UV/visible light irradiation. PPE-DABCO and EO-OPE-1(DABCO), which are both
functionalized with DABCO-based quaternary ammonium groups (Scheme 1.3),
exhibited the highest dark fungal inactivation activities among the tested agents. The high
activities are likely due in part to the unique structural features of the compounds. The
DABCO-based quaternary ammonium groups possess the highest positive charge density
on its side chains among the CPEs and OPEs used in this study, which may enable these
compounds to most strongly associate with the negatively charged cell surface and induce
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the greatest degree of disruption of the self-assembled protein structures on the cell wall.
This could cause the integrity of the cell envelope to be compromised. Moreover, the
proteins on the cell surface could readily react with singlet oxygen and secondary ROS
species generated by the CPEs and OPEs under UV-irradiation, leading to a higher extent
of inactivation.
Microorganisms always exhibit various biological characters during their life cycle,19
such as viability and metabolic activity, thus the cells at different growth phases may
show different susceptibilities to the biocidal agents. Figure 6.2 shows that the
susceptibility of vegetative S. cerevisiae cells to the dark antifungal activity of EO-OPE1(Th, C2) varies with growth phase. Yeast cells grow exponentially for the first 12 hours
in the YPD medium, after which the cells shift to diauxic and postdiauxic phases.19 After
continuous growth for about 1 week in the same medium, the cells enter the stationary
phase.19 The level of nutrients is one of the main factors controlling the cell cycle and the
stationary phase has been recognized as a dormancy state in response to nutrient
starvation.19 As shown in Figure 6.2, EO-OPE-1(Th, C2) exhibited growth phasedependent dark antifungal activities, where the inactivation activity increased during the
first 24 hours of incubation, during which the yeast cells had undergone rapid growth
with high metabolism and are highly susceptible to EO-OPE-1 (Th, C2)-induced toxicity.
When glucose becomes exhausted, cells switch from fermentative growth to respiratory
metabolism and grow at a much lower rate.19 As shown, the metabolically inactive yeast
cells were more resistant to the biocidal activity of EO-OPE-1(Th, C2) after 24 hours in
YPD medium (Figure 6.2). These results imply that the dark antifungal activities of the
CPEs and OPEs are dependent on the metabolism of the yeast cells, and the cells are
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more susceptible when they are metabolically active. It is also important to note that the
light-enhanced activity of EO-OPE-1(Th, C2) were growth phase-independent under the
conditions tested. After exposure to the UV-light (4 lamps, 30 min), 10 µg/ml EO-OPE1(Th, C2) completely inactivated the vegetative cells (~106 CFU/ml) at all of the tested
growth phases. Thus in addition to damage caused to the cell envelope, it is possible that
the CPEs and OPEs may be taken up by the yeast cells and interfere with metabolic
pathways, thereby contributing to cell death. This seems particularly plausible in the case
of damage caused in the dark, given that killing in the dark was dependent on the
metabolic state of the cells.

Figure 6.2. Inactivation of vegetative S. cerevisiae cells (ATCC 9763) (~106 CFU/ml) at
different growth phases by 10 µg/ml EO-OPE-1(Th, C2) in the dark for 60 min. Only
~105 CFU/ml of the yeast cells were alive after 168 hours continuous incubation. The
growth phases are determined based on Ref. 19.
6.2.2 CPEs and OPEs exhibit limited sporicidal activities
Inactivation of bacterial and fungal spores is widely recognized as being more difficult
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than the killing of vegetative cells, and therefore spores present a special challenge to
human health. As described, ascospores have a multilayered protective coat and
moreover, ascospores are covered by an additional layer of ascal membrane and wall
(Scheme 6.1). These structures enable ascospores to be highly resistant to environmental
stresses and damages and the inactivation of these organism requires damages to and
penetration through both the ascal layer as well as the spore coat.
As shown in Figure 6.3, in the absence of UV-light, none of the tested oligomers or
polymers was effective at inactivating ascospores after 60 minutes of incubation. The
viability of ascospores did not decrease after treatment with OPE-3 (30 µg/ml) for 5
hours in the dark (data not shown). In contrast, upon treatment with EO-OPE-1(Th, C2)
and strong UV-irradiation (10 lamps), ascospore viability decreased about 95% within 1
hour (Figure 6.3). No increased sporicidal efficiency was observed for EO-OPE-1(Th, C2)
after extended UV-light exposure (3 hours). All other tested oligomers and polymers
were essentially inactive with UV-light irradiation under the current experimental
conditions. Our results indicate that, except EO-OPE-1(Th, C2), other tested biocidal
agents may not be able to disrupt or penetrate through the ascal coat or spore coat.
Working with Bacillus spores, Kane and coworkers showed that upon germination,
spores become more susceptible to biocidal agents.16 In the presence of germinant, that
can trigger the spore germination program, the ascal and spore coats could be removed
and the spore re-entries into the vegetative cell cycle.11 Herein, we tested the effect of
germination on the susceptibility of yeast ascospores to the CPEs and OPEs. The
ascospores were first treated with 2% glucose and 0.37% NH4Cl for 20 hours to promote
germination. Then the germinated spores were incubated with a CPE or OPE in the dark
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or under UV-irradiation for 1 hour. As shown in Figure 6.4, in the dark, 30 µg/ml of EOOPE-1(C3), EO-OPE-1(Th, C2) and OPE-3 resulted in more than 50% reduction in the
viability of germinated spores. Moreover, all of the tested agents became effective at
reducing spore viability with UV light irradiation. EO-OPE-1(Th, C2) inactivated more
than 95% of the germinated spores and showed the highest light-enhanced biocidal
efficacy compared to other polymers or oligomers. It is interesting to note that PPEDABCO and EO-OPE-1(DABCO) did not exhibit any biocidal effect agains the
germinated ascospores in the dark, while they were fairly active against the vegetative
cells (Figure 6.1). This could be due to the existence of the extra ascus coat outside the
ascospores. The ascus coat is derived from the envelope of the vegetative mother cell,
and thereby has similar characteristics, such as chemical components and net charge, to
those of the mother cell envelope. Since the DABCO functionalized oligomers and
polymers readily associate to the vegetative cell envelope, they are expected to bind to
the ascus coat with high affinity. Once bound to the coat, the polymer or oligomer
molecules can become hindered from binding to and damaging the germinated spores
underneath the coat.
The EO-OPE-1(Th, C2) oligomer exhibited efficient biocidal activity against both
dormant and germinated ascospores under UV-light irradiation, probably due to its ability
to sensitize singlet oxygen species with a high quantum yield in addition to its high
solubility in water.5, 20 However, none of the tested agents reduced the number of CFU by
more than 2 orders of magnitude against the germinated ascospores. Even when the
germinated spores were treated with 30 µg/ml OPE-3 for extended periods (2 to 3 hours)
with UV-light exposure, no improvement in biocidal activity was observed. Rine and co-
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workers have reported that 2% glucose can germinate 95% of the yeast spores (~107/ml)
within 12 hours. Although the ascospores samples employed in our study were incubated
for 20 hours in 2% glucose to promote complete germination, viewing the ascospores
under a light microscope showed that a number of the spores did not undergo germination
(data not shown). Incomplete germination of the spores can account the low inactivation
levels shown in Figure 6.4. Additionally, although YPD is an excellent germination
medium, bio-macromolecules in this rich medium, such as proteins and nucleic acids,
may bind to the CPEs and OPEs, attenuating their biocidal activities.

Figure 6.3. Inactivation of S. cerevisiae ascospores (ATCC 204722) (~2×106 CFU/ml)
by CPEs or OPEs (30 µg/ml) in the dark (blue bars) or with UV-light irradiation (red bars,
10 UV-lamps) for 60 min. UVA and LZC-420 irradiation alone did not cause spore
inactivation under the experimental conditions.
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Figure 6.4. Inactivation of the germinated S. cerevisiae ascospores (ATCC 204722)
(~2×106 CFU/ml) by CPEs or OPEs (30 µg/ml) in the dark (blue bars) or with UV-light
irradiation (red bars, 10 UV lamps) for 60 min. UVA and LZC-420 irradiation alone did
not cause obvious spore inactivation under these current experimental conditions.
6.2.3 CEPs and OPEs induced morphological damages to S. cerevisiae vegetative
cells and asci
In order to gain some insights to the antifungal and sporicidal activities of the CPEs
and OPEs, morphological changes of yeast cells and ascospores in response to exposure
to the different agents were examined by SEM imaging. As shown in 6.5A, the vegetative
cells alone in PBS buffer maintained their integrity with smooth cell surfaces. Yeast cells
treated with EO-OPE-1(C3) in the dark remained intact, but cell surfaces appeared rough
and wrinkled (Figures 6.5B). Some of the PPE-Th treated cells exhibited obvious
morphological damages (Figure 6.5C) compared to the untreated samples, and significant
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cell envelope defects were observed. PPE-Th has been demonstrated to associate strongly
with and denature anionic proteins, and it may bind to the anionic groups on the yeast cell
surface and induce lethal defects. The sample preparation process for SEM imaging may
amplify these defects and result in large holes on the cell surface.21 Similar to the
untreated cells (Figure 6.5A), control yeast cells irradiated by the UV-light for 30 min
without the addition of biocidal agents appeared intact with smooth surfaces (Figure
6.6A), consistent with our findings that UV-irradiation alone caused low-levels of
toxicity to the vegetative cells (Figure 6.1). However, the addition of oligomeric EOOPE-1(C3) or EO-OPE-1(Th, C2) with UV-irradiation caused significant changes to the
cell envelope (Figure 6.6B and D). Similar to the damage seen in the dark, PPE-Th
disrupted the cell envelope and created large defects on the cell surface (Figure 6.6C).
However, roughening and wrinkling of the cell surface were not observed. The polymeric
PPE-Th and oligomeric EO-OPEs induced different types of damages to the yeast cells
both in the dark and with UV-irradiation, which may be due to the permeability of the
cell wall top layer. The glycosylated mannoproteins with branched carbohydrate side
chains on the cell surface can render the cell wall impermeable to the polymeric PPE-Th.
As a result, the relatively hydrophobic PPE-Th chains may aggregate22 and act to create
defects on the cell surface. However, the EO-OPEs with a nearly linear conformation
may penetrate deeper into the cell envelope and reorganize the layered structure of the
cell envelope. It is important to note that the yeast cells seem to be damaged to different
extents by the biocidal compounds (Figure 6.5 and 6.6), which probably is due to the
non-uniform binding of these compounds toward the yeast cells.
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Figure 6.5. SEM images of S. cerevisiae vegetative cells alone (ATCC 9763) (~2×106
CFU/ml) (A) and incubated with 10 µg/ml antimicrobial EO-OPE-1(C3) (B) or PPE-Th
(C) for one hour in the dark.

Figure 6.6. SEM images of S. cerevisiae vegetative cells (ATCC 9763) (~2×106 CFU/ml)
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alone (A) and incubated with 10 µg/ml EO-OPE-1(C3) (B) or PPE-Th (C) or EO-OPE1(Th, C2) (D) for 30 min with UV-light irradiation (4 lamps).
EO-OPE-1(Th, C2) was shown to inactivate more than 95% of dormant and germinated
yeast ascospores (Figures 6.3 and 6.4). As shown in Figure 6.7A, the ascus exhibits a
classic tetrahedral shape with a smooth coat and each individual ascospore is clearly seen
in the ascus. With UV-light irradiation alone, the ascus coat became ridged in appearance,
while maintaining its structural integrity and continued to enclose the ascospores (Figure
6.7B). After treatment with EO-OPE-1(Th, C2) in the presence of UV-light (Figure 6.7D),
asci exhibited similar structural features as shown in Figure 6.7B and no further
morphological damage could be observed to the asci, implying that the oligomer may use
other mechanisms to inactivate the ascospores.
In contrast to the asci, germinated ascospores have a distinctive appearance and a
smaller size (Figure 6.7C), indicating that the ascus coat may be partially removed during
the germination process. The addition of EO-OPE-1(Th, C2) with UV-irradiation caused
obvious damages to the surface of the germinated spores with the vegetative cell wall
(Figure 6.7E, see arrows), which appeared very similar to the vegetative cells treated by
the oligomer with UV-light (Figures 6.6B and 6.6D).
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Figure 6.7. SEM images of A. an S. cerevisiae ascus containing four ascospores (ATCC
204722) (~106 CFU/ml), B. an ascus irradiated with UV-light, C. germinated asci
irradiated with UV-light, D. asci incubated with 30 µg/ml EO-OPE-1(Th, C2) and
irradiated with UV-light for 1 hour, and E. germinated asci incubated with 30 µg/ml EOOPE-1(Th, C2) and irradiated with UV-light for 1 hour. All UV-irradiation experiments
were carried out with 10 lamps.
6.3 Conclusions
This study explored the antifungal and sporicidal activities of the arylene-ethynylenebased CPEs and OPEs using S. cerevisiae as a model pathogen toward the goal of
extending the utility of these polymers and oligomers as biocidal agents. In the dark, the
CPEs and OPEs exhibited moderate inactivation of vegetative yeast cells. In particular,
PPE-DABCO, EO-OPE-1(DABCO) and OPE-3 showed comparable or higher antifungal
activities compared to the widely-used antibiotic AmB. With UV-irradiation, all of the
tested agents induced more than 6-log reductions in yeast cell viability. Moreover,
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antifungal activities of the compounds were shown to be dependent on the growth phase
of the yeast cells where cells in growth phases that correspond to higher metabolic
activities were more susceptible to the biocidal activities of CPEs and OPEs. These
materials showed limited inactivation activities towards ascospores. In the dark, all
compounds tested were not effective at reducing spore viability and with UV irradiation,
only EO-OPE-1(Th, C2) was active, inactivating more than 95% of the yeast ascospores.
The compounds were more effective at inactivating ascospores once they undergo
germination, where the tested agents showed inactivation activity with UV-light
irradiation. SEM imaging revealed that the envelopes of the vegetative cell and
germinated ascospore are targets of the CPEs and OPEs.
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Chapter 7 Antiviral Activity of the CPEs and OPEs
7.1 Introduction
The work discussed in previous chapters has shown that the cationic PPE-based
polymers and oligomers display significant photoinducible antimicrobial activity in both
Gram-positive and Gram-negative bacteria. The direct contact between these
antimicrobial compounds and microorganisms followed by the generation of corrosive
reactive oxygen species (ROS) after exposure to UV-visible light appears to account for
the high bactericidal activity of these cationic PPE-based materials.
In addition to health threats caused by bacterial infections, many serious diseases are
caused by viruses. The most notable example is human immunodeficiency virus induced
Acquired Immune Deficiency Syndrome (HIV-AIDS), which has infected an estimated
33.3 million people.1 Current interferon-based treatments for virus-caused diseases and
current wastewater treatments against viral-contamination are inadequate.2 The
development of new antiviral agents is a critical worldwide healthcare need. Given our
increased understanding of the mechanism of dark and light-induced inactivation of
bacteria by the PPE polymers and oligomers, we suspected that these materials might also
be effective against viruses. Here, we investigate the antiviral activities of a series of
CPEs and OPEs against two model viruses, the MS2 and T4 bacteriophages. The
structures and compositions of these bacteriophages have been extensively investigated.35

Bacteriophage MS2 is a non-enveloped, ~27 nm RNA virus with a small single-

stranded RNA genome of ~3600 nucleotides. Its structure is very similar to some
members of the picornavirus family, which are important human and animal viral
pathogens.6 Bacteriophage T4 is a relative large, non-enveloped 170 kbp double-stranded
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DNA virus with a 120 by 86 nm head and a 100 nm tail. These two bacteriophages are
commonly used as model systems for environmental pollution and virus detection
studies.7
The isoelectric points of the MS2 and T4 phage particles are 3.9 and 4~5,
respectively,8 which render them slightly negatively charged in neutral buffers. Thus, our
cationic CPEs and OPEs are expected to readily associate with the phage particles and
possibly attenuate their recognition and binding to host cells. Previously, we proposed
that after exposure to UV-visible light, the CPEs and OPEs can generate singlet oxygen
species followed by the formation of more corrosive reactive oxygen intermediates.9 This
property of the CPEs and OPEs is due to the conjugated π bonding system in the
backbone of the compounds, which allows for efficient intersystem crossing to a triplet
state that sensitizes the formation of singlet oxygen 1O2. 1O2 and the subsequent ROS
intermediates are known to be highly damaging to biomolecules, including proteins,
RNA and DNA.10 In addition, the association of CPEs and OPEs with biological
structures, in the absence of any irradiation, has been shown to disrupt non-covalent
biomolecular assemblies, including the lipid membrane,11 and folded protein structures.
The major components of viruses are proteins, RNA or DNA. Moreover, the virus capsid,
which encloses the genetic material of the virus, is made of non-covalently assembled
proteins.
In the current study, we evaluate the antiviral activities of a number of CPE and OPE
compounds against two model viruses in the presence and absence of UV or short
wavelength visible light using biological (infectivity) and morphological structural (TEM)
assays. SDS-PAGE provides additional insights into the mechanism of the light-induced
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inactivation mechanism of CPEs and OPEs.
7.2 Results and Discussion
The phage titer assay was carried out by a serial dilution of phage-CPE/OPE mixture
and incubating each diluted sample with the corresponding E. coli host cells within
molten soft LB agar. Since our previous work demonstrated that the CPEs/OPEs can
efficiently inactivate E. coli cells,12-14 which may interfere with the plaque assay, it is
necessary to study the effect of residual CPEs/OPEs on the E. coli host cells. For the
control experiment without phage and CPEs/OPEs, E. coli forms a confluent cell sheet on
the soft agar after 6 hours of incubation at 37°C. Under the current experimental
conditions, 0.33 µg/ml was the maximum concentration of residual CPEs/OPEs in the
soft agar (100 µl inactivated phage sample by 10 µg/ml CPEs/OPEs was mixed with 3 ml
melted soft agar), which did not cause any obvious defects in the bacterial cell sheet.
7.2.1 CPEs and OPEs exhibit efficient phage inactivation ability
Figure 7.1 summarizes T4 and MS2 phage inactivation induced by different CPE and
OPE compounds in the dark (black bars) or with UV/visible irradiation (blue bars). The
effect of irradiation alone (red bars) on phage inactivation was also determined. Even in
the absence of UV or visible light, PPE-DABCO and EO-OPE-1(Th) exhibit significant
antiviral activities against the T4 phage, reducing the number of PFU by 6 and 3 orders of
magnitudes, respectively. In comparison, PPE-Th, OPE-1 and EO-OPE-1(C3) are less
active in the dark, albeit inducing ca. 1 order of magnitude of inactivation. No dark
inactivation activity is observed for OPE-3 against the T4 phage. UV irradiation
enhanced the inactivation of the T4 phage induced by all CPEs and OPEs. For example,
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UV light enhanced PPE-Th and EO-OPE-1(C3)-induced inactivation by about 5 and 3
orders of magnitude compared to inactivation by the compounds in the dark. Whereas
OPE-3 was ineffective in the dark, a 3 order of magnitude decrease in PFU was observed
with UV irradiation.
Compared with the inactivation of T4 phage, all CPEs and OPEs tested were more
efficient at inactivating the MS2 phage in the dark (Figure 7.1B). All compounds, except
OPE-1 and EO-OPE-1(C3), induced more than 6-log inactivation against MS2 phage in
the dark. With UV irradiation, OPE-1 and EO-OPE-1(C3) became very efficient at
inactivating the MS2 phage.
Of the materials tested, PPE-DABCO exhibited the highest virus inactivation activity,
inducing more than 6 orders of magnitude of inactivation of both model viruses in the
dark and with UV irradiation. The high antivirial activity of PPE-DABCO is likely due in
part to its unique structural features. The polymer possesses the highest positive charge
density on its side chains among the CPEs and OPEs tested in this study, which gives
PPE-DABCO the ability to easily associate with the negatively charged viruses. In
addition, the bulky side chains with highly hydrophobic yet positively charged groups of
the PPE-DABCO prevent self-aggregation thus making more of the polymer available to
associate with the phage particles.
Our results also showed that all of the oligomers exhibit more efficient dark
inactivation activity against the MS2 phage than the T4 phage. This could be due in part
to the presence of 32 pores15 (1.8 nm in diameter) on the MS2 capsid that provide easier
access for the oligomers to interact with the packaged phage genome. It is also worth
noting that long wavelength UV-visible light (LZC-420) alone produces negligible
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inactivation of the viruses (UV control data for polymeric PPE-DABCO and PPE-Th
samples in Figure 7.1). In contrast, UVA irradiation alone in the absence of the oligomers
causes measurable inactivation of both viruses (UV control data for oligomeric OPE-1,
OPE-3, EO-OPE-1(C3), and EO-OPE-1(Th) samples in Figure 7.1). Moreover, UVA
irradiation caused a higher level of virus inactivation of T4 compared to MS2. The
different effects of UV light on the model viruses could be explained by T4’s higher
susceptibility to chemical damage. Upon exposure to UVA irradiation, adjacent
thymidine residues in the T4 phage DNA genome can covalently link to form thymidine
dimers,16 and can to a lesser extent also induce protein-DNA photocrosslinking leading
the inactivation of T4 phage. While UVA can cause protein-RNA photocrosslinking,
RNA does not contain thymine, and uracil photodimerization is very rare.
It is clear from our data that the cationic CPE and OPE compounds tested show
efficient inactivation activity against the two model viruses. The first step in viral
infection is the recognition and binding of the viruses to the surface of the host cells. The
T4 bacteriophage infection is initiated by the recognition of the lipopolysaccharides and
the OmpC protein on the surface of host E. coli cells and followed by release of the phage
genome into the host for replication.17 Although the exact infection pathway of the MS2
phage is not clear, it is believed that the pilus of E. coli cells is a potential receptor for the
MS2 phage.18 The cationic CPEs and OPEs are expected to bind to the slightly negatively
charged T4 and MS2 virus surfaces through electrostatic interactions. Thus, it is
reasonable to assume that the antiviral activities of the PPE and OPE compounds are due
in part from their ability to shield the virus particles from the host cells. Meanwhile, it is
worth noting that since the sorption of the CPEs and OPEs to the viral particles is not

157

fully understood, it is possible for the absorbed antiviral compounds to be desorbed with
a change in the environmental conditions (such as solution pH and ionic strength) without
causing lethal damage to the bacteriophages. We have shown previously that the CPE and
OPE compounds can disrupt non-covalent biomolecular assemblies and generate reactive
oxygen species with UV-visible light exposure, which can strongly damage biomolecules,
including proteins that make up the virus capsid.10, 19 We examined below if the binding
of the compounds to virus particles results in further capsid damage.
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Figure 7.1. Inactivation of the T4 (A) and MS2 (B) bacterialphages by CPEs or OPEs in
the dark (black bars) or with UV-light irradiation (blue bars). UV control samples (red
bars) were those exposed to irradiation alone. The detection limit for the assay is 6 to7
logs of PFU/ml.
7.2.2 PPE-DABCO and EO-OPE-1(Th) disrupt viral morphology
To visualize the changes in viral morphology induced by PPE-DABCO and EO-OPE1(Th), virus samples exposed to the compounds were imaged by TEM. Representative
images (out of more than 10 collected) are shown in Figure 7.2. As a control, the
untreated T4 phage shows its classic morphology with intact icosahedral head and tail
structure (Figure 7.2 A1). In contrast, when exposed to PPE-DABCO or EO-OPE-1(Th),
both in the dark as well as with UV-light exposure, significant changes to the virus
morphology are observed. As shown in Figure 7.2 B1, the tail of the T4 phage is
detached from the head in the presence of PPE-DABCO in the dark. Significant damage
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is also observed to the head of the T4 phage with the addition of PPE-DABCO in the
light or with EO-OPE-1(Th) in the dark and under irradiation (Figure 7.2C1, D1 and E1).
Likewise, the untreated MS2 phage are uniformly sized and spherically shaped (Figure
7.2 A2). When exposed to PPE-DABCO and EO-OPE-1(Th) in the dark, the surface of
the phage particles became rough and wrinkled (Figure 7.2 B2 and D2). MS2 phage
treated with PPE-DABCO or EO-OPE-1(Th) with UV light irradiation exhibited
significant disruption (Figure 7.2 C2 and E2).

Figure 7.2. TEM images of the T4 and MS2 viruses alone (A1 and A2) and incubated
with PPE-DABCO (B1 and B2, in the dark; C1 and C2, with UV irradiation) or EO-OPE1 (Th) (D1 and D2, in the dark; E1 and E2, with UV irradiation) for one hour. The scale
bars of the T4 images are 100 nm and the scale bars of the MS2 images are 20 nm.
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Figure 7.3. SDS-PAGE gels of the MS2 phage capsid. Lane A1: protein marker (BIORAD); Lane A2 and B1: phage alone in the dark; Lane B2: phage irradiated with UVA;
Lane B3: phage with 20 µg/ml EO-OPE-1(Th) in the dark; Lane B4: phage with 40
µg/ml EO-OPE-1(Th) in the dark; Lane B5: phage with 20 µg/ml EO-OPE-1(Th)
irradiated with UVA; Lane B6: phage with 40 µg/ml EO-OPE-1(Th) irradiated with
UVA.
7.2.3 EO-OPE-1(Th) damages MS2 capsid protein with UV irradiation
To assess the extent of damage to the virus capsid induced by the CPE and OPE
compounds, the capsid proteins of the MS2 bacteriophage were analyzed with SDSPAGE. The MS2 capsid is comprised of 180 copies of a coat protein with a molecular
weight of ~ 13.7 kDa and one copy of the maturase protein with a molecular weight of ~
44 kDa.3, 20 The band in lane 2 in Figure 7.3A from isolated MS2 phage particles is in
agreement with expected molecular weight of the phage coat protein. Lanes 2-4 in Figure
7.3B show the coat protein band of viruses exposed to UVA irradiation alone and with
EO-OPE-1(Th) in the dark. UV irradiation alone (Figure 7.3B, band 2) or the presence of
EO-OPE-1(Th) in the dark (band 3 and 4) did not cause any significant changes to the
coat protein band, indicating that these two conditions did not cause either aggregation or
cleavage to the virus coat proteins. In contrast, the coat protein bands of MS2 in the
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presence of EO-OPE-1(Th) with UVA irradiation showed a band with significantly
decreased intensity (Figure 7.3B, bands 5 and 6), indicating that the reactive oxygen
species generated by the irradiation of EO-OPE-1(Th) has caused almost complete
modification of the coat protein. However, the degradation products have not been
characterized in the present study.
MS2 phage inactivation data in Figure 7.1B show that the oligomer EO-OPE-1(Th) is
very potent at inactivating the virus both in the dark and with UV irradiation, reducing
the number of plaques by over 6 orders of magnitude. Our gel electrophoresis results
show that virus inactivation in the dark and with UV irradiation proceeds through
different mechanisms. No damage to the monomeric coat protein occurred with the virus
particles exposed to the oligomer alone, implying that EO-OPE-1(Th) exerts its dark
phage inactivation activity through physical binding to the phage particles, followed by
possible remodeling of capsid architecture. Meanwhile, UV irradiation in the presence of
the oligomer induced almost complete degradation of the virus coat protein. Thus, the
mechanism of the antiviral properties of the CPEs and OPEs may be comprised of at least
three parts: (1) Association of these cationic compounds with the virus particles
attenuates virus recognition and binding to host cells. (2) The compounds disrupt the
architecture or morphology of the virus capsid, and (3) UV-induced generation of
reactive oxygen species by the PPE-based compounds has the potential ability to
covalently modify the capsid coat proteins.
7.3 Conclusions
In summary, the current study expands upon the utility of the PPE-based CPEs and
OPEs as antimicrobials and it underscores that (1) most of these compounds exhibited
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high dark inactivation activity against the MS2 phage and moderate dark inactivation
ability against the T4 phage through the inhibition of their infection pathway and/or the
destruction of the virus structures, and (2) the UV light-enhanced antiviral activity of the
CPEs and OPEs is achieved by the generation of corrosive reactive oxygen species,
which can chemically damage the capsid protein of the model viruses.
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Chapter 8 Summary and Future Directions
8.1 Summary
In this dissertation, I have summarized findings from multiple investigations of the
interactions of CPEs and OPEs with potential pathogens such as Gram-negative and
Gram-positive bacteria, model viruses, and fungi, and fungus spore. We have also
discussed the interactions of these synthetic materials with model membrane systems and
cell components such as proteins, nucleic acids and cellulose materials in a effort to
better understand the interactions on a molecular scale.
We examined the interactions of biocidal CPE and OPE materials with model
membrane systems in an effort to understand the underlying mechanism and selectivity of
their biocidal activity. Electrostatic interactions are important for the initial binding
between the CPEs and OPEs with lipid membranes and the presence of lipids with
negative intrinsic curvature can facilitate membrane disruption or phase transition
induced by CPEs and OPEs. In addition, the membrane activity of these materials is also
dependent on molecular conformation and size, as well as the structure of side chains.
Since in vitro membrane activity measurements of the synthetic antimicrobial agents
correlates well with their biocidal activity and selectivity, these studies may guide the
rational design of more efficient synthetic antimicrobial materials.
Our studies have also shown that for most CPE/OPE-biological systems investigated,
there are two pathways for pathogen inactivation: a dark process in which the CPE/OPE
associates with and/or penetrates the outer envelope of the pathogen and a light-activated
process in which a reactive oxygen species, initially singlet oxygen in most cases, is
generated either at or within the envelope of the pathogen. Both dark and light activated
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pathways induce disruptions to the physical and chemical stabilities, and thereby
functions, of biological targets, thus inducing toxicity. These toxicity mechanisms are
non-specific and underlie the remarkable broad-spectrum biocidal activity observed.
Importantly, our findings support the development and use of these materials as novel
antimicrobial agents that are unlikely to induce resistance. Furthermore, these materials
are relatively easy to synthesize, stable, and amenable to be processed into different
materials, including coatings and fibers, which could greatly expand their applications
into antiseptic materials for preventing and limiting the spread of infections, including
sterile clothing and paints, biocompatible medical materials such as catheters, sutures,
and implants.
8.2 Future directions
8.2.1 Membrane perturbation mechanisms
As described previously, more experimental studies are necessary to construct a more
complete picture describing the membrane perturbation mechanisms and the structure–
function relationships of the CPEs and OPEs.
To evaluate the effect of CPE/OPE-membrane interactions on membrane stability and
permeability, we have proposed to measure the effects of the materials on the molecular
structure and permeabilization of model lipid membranes. On the molecular level,
destabilization of supported lipid bilayers will be assessed by neutron reflectivity (NR)
(LANSCE, LANL, Los Alamos, NM).1 Briefly, a lipid bilayer will be prepared on a
quartz surface using a Langmuir-Blodgett/Langmuir-Schaefer (LBLS) deposition method.
This preparation method yields bilayers with near complete surface coverage so that the
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effect of membrane disruption by the biocides can be resolved. The bilayer will then be
sealed in a solid-liquid interface fluid cell and NR data will be collected before and after
the injection of a CPE/OPE sample. Different hydrogen-deuterium schemes will be tested
for optimal contrast. From our experience, hydrogenated lipids and polymers with D2O
superphase provide excellent contract for detecting membrane structure, while the
deuterated oligomer with hydrogenated lipids and superphase will allow us to easily
determine the location of the biocide. Changes in lipid membrane phase will continue to
be determined by small angle X-ray scattering (SSRL, SLAC National Accelerator
Laboratory, Menlo Park, CA).2 Changes in lipid bilayer structure and morphology will be
evaluated by AFM imaging of supported bilayer patches formed by rupturing unilamellar
vesicle on mica surface in a fluid cell before and after incubation with a CPE/OPE.
Bilayer patch height, area, edge appearance, and possible surface deformation and
resulting biocide/lipid structures will be imaged and determined to assess the mechanism
of membrane destabilization.
8.2.2 Interaction of the CPEs and OPEs with live pathogen in aqueous environment
The morphological damage to the model pathogens have been routinely visualized by
conventional SEM and TEM in our study. But the sample preparation process for these
imaging techniques may create artifacts3 and the interactions of the CPEs and OPEs with
living pathogens can not be visualized by these techniques. The atomic force microscopy
(AFM) has been applied in the studies of dynamic biological process, for example, the
growth and septum formation of S. aureus have been imaged by AFM in aqueous
environment.4 Real-time investigation of the interactions between the PPE-based
antimicrobial materials and a single living pathogen cell in the aqueous environment via
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AFM will provide more insights into the biocidal mechanisms of the CPEs and OPEs.
8.2.3 Antimicrobial selecity of the CPEs and OPEs and their delivery
To fully realize the potential of these PPE-based materials as new antibiotics and novel
antiseptic materials, rational design of the materials to optimize activity and selectivity
for different applications need be guided by a fundamental understanding of the
antimicrobial mechanisms and the structure-function relationship of these materials.
As discussed in the preceding chapters, there may be both important concerns and
opportunities in the ability of CPE/OPE materials to damage mammalian cells. Thus
future work will be targeted to render CPE/OPE materials more selective in some cases
so that they can be used perhaps in the presence of mammalian cells without damaging
them. Since in general the concentration of CPE or OPE materials sufficient to damage
bacterial cells is usually much lower than that necessary for damaging mammalian cells,
it might be useful to develop formats where the CPE or OPE materials are loaded on
nanoparticles such as Laponite,5 that have been proposed as a non-harmful carrier for
drug delivery. The larger CPE may remain bound to the nanoparticulate Laponite while
the smaller OPE may be released at very low concentrations. Additionally by coupling
the loading of a CPE or OPE onto nanoparticles with the binding of a recognition element
such as a peptide or antibody can target the CPE or OPE to specific cell types or
pathogens.
The most recent studies we have reported where the smaller OPE (end-only
functionalized) have been found active against hard to inactivate (or destroy) biofilms
and yeast cells (fungi) and spores suggest that these materials are sufficiently versatile for
uses in the large space between peptides and synthetic antibiotics and harsh reagents such
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as bleach and other materials generating reactive oxygen intermediates or chloride
reagents.
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